[{"text": "GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide NewMediaWire Mon, Jan 27, 2025, 5:00 PM 4 min read In This Article: GOVX -7.33% GOVXW -22.92% Process Expected to Increase Production Yield, Flexibility at Lower Cost ATLANTA, GA - January 27, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company specializing in vaccines and immunotherapies, has shared updates about its development-stage advanced Modified Vaccinia Ankara (MVA) vaccine manufacturing process. This anticipated process provides the potential to not only address today's pressing health challenges but also paves the way for more efficient, flexible and lower-cost MVA-vaccine manufacturing. The Power and Versatility of the MVA Platform The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or several pathogens simultaneously. Originally developed as a safer smallpox vaccine, the MVA platform offers distinct advantages, including: Protection against diseases such as Mpox and smallpox. Multi-antigen vaccines like GEO-CM04S1, which targets both the Spike (S) and Nucleocapsid (N) antigens of SARS-CoV-2. Stability under minimal refrigeration and the potential for freeze-drying (lyophilization), simplifying distribution in resource-limited settings. Advancing MVA Manufacturing Current vaccine manufacturing methods rely on Chicken Embryo Fibroblast (CEF) cells, requiring pathogen-free eggs. This process is costly, time-consuming, and dependent on limited egg supplies, providing barriers to rapid, real-time MVA manufacturing, as well as hindering the flexibility necessary to establish local MVA manufacturing of critically important vaccines. GeoVax is addressing these barriers through an advanced MVA Manufacturing process utilizing an avian cell line licensed from ProBioGen AG (Berlin). Key features include: A continuous avian suspension cell line process that eliminates the need for pathogen-free eggs. Compatibility with standard manufacturing equipment, reducing setup time, simplifying the MVA manufacturing process, increasing scalability and lowering manufacturing costs. This advanced MVA manufacturing process is expected to significantly simplify vaccine production, particularly in middle- and low-income regions where supply chain issues often hinder access to critical vaccines. Addressing Global Health Needs \"Our advanced MVA manufacturing process represents not only a transformative manufacturing advance but also addresses a public health imperative,\" said David Dodd, Chairman and CEO of GeoVax. \"By tackling disease protection, logistical hurdles, and manufacturing challenges, we aim to empower regions like Africa with the tools needed to combat current and future health crises.\" Story Continues GeoVax's MVA vaccines have demonstrated robust performance in clinical trials, with ongoing Phase 2 studies for GEO-CM04S1, its COVID-19 vaccine candidate, showing broad and durable immune responses. Supported by its BARDA Project NextGen Award and partnerships with leading manufacturing and development organizations, GeoVax is positioned to enhance vaccine access and delivery on a global scale. Recent Conference Presentations GeoVax CEO David Dodd recently presented the company's strategic initiatives and the potential of GEO-MVA at: Biotech Showcase: January 14, 2025 Emerging Growth Conference: January 16, 2025 About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin(R) combined with an immune checkpoint inhibitor is planned to initiate in mid-2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com . Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words \"believe,\" \"look forward to,\" \"may,\" \"estimate,\" \"continue,\" \"anticipate,\" \"intend,\" \"should,\" \"plan,\" \"could,\" \"target,\" \"potential,\" \"is likely,\" \"will,\" \"expect\" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: Investor Relations Contact: Media Contact: info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com 678-384-7220 212-698-8696 202-779-0929 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-27T14:00:00+00:00", "sentiment": {"score": 0.5711280507966876, "confidence": 0.5834531188011169, "probabilities": {"positive": 0.5834531188011169, "negative": 0.01232506800442934, "neutral": 0.4042218029499054}}, "embedding": [-0.09826677292585373, -0.10242576897144318, -0.02586536481976509, -0.21276065707206726, -0.006709208711981773, 0.0010421117767691612, -0.023531606420874596, 0.10287025570869446, 0.058623455464839935, 0.12144692242145538, -0.12731128931045532, 0.10612459480762482, 0.10793319344520569, 0.10279569029808044, -0.12796655297279358, -0.032312944531440735, 0.038916751742362976, 0.041981667280197144, -0.022738825529813766, 0.07557116448879242, 0.0880170539021492, -0.057022929191589355, 0.0139823779463768, 0.028310777619481087, -0.21493962407112122, 0.016236569732427597, -0.03463592752814293, 0.031079573556780815, -0.12161590158939362, -0.12577101588249207, -0.09229347109794617, -0.05864591896533966, -0.06651859730482101, -0.10763391107320786, 0.0039640143513679504, 0.021583955734968185, -0.06593987345695496, 0.09218540787696838, -0.008381153456866741, -0.05322727560997009, 0.011057939380407333, 0.03087634965777397, -0.02784666046500206, 0.027766967192292213, 0.07560145854949951, -0.0896354615688324, -0.023323917761445045, -0.054700128734111786, 0.12980163097381592, 0.059989478439092636, -0.1107567623257637, -0.2484510987997055, -0.09015778452157974, 0.08141598105430603, -0.005506092682480812, -0.016365008428692818, -0.2220628559589386, -0.09388088434934616, -0.011279158294200897, -0.11002831906080246, -0.11961351335048676, -0.12719103693962097, 0.07189114391803741, -0.009373366832733154, 0.03557239845395088, -0.06958402693271637, 0.07956284284591675, -0.011157531291246414, -0.04636179655790329, -0.14277499914169312, -0.04656624048948288, 0.16527560353279114, -0.039009980857372284, 0.2017316371202469, -0.06327535212039948, 0.2211160659790039, 0.2316352128982544, 0.07193130999803543, 0.28251737356185913, 0.0817885547876358, 0.12505343556404114, 0.16083687543869019, 0.04638301208615303, 0.02731473743915558, -0.02433924376964569, 0.1233845204114914, 0.09163926541805267, 0.09556381404399872, 0.24280908703804016, -0.06505902856588364, 0.23936055600643158, 0.09932561218738556, 0.028654400259256363, 0.10199090838432312, 0.13836146891117096, -0.07757808268070221, 0.050320230424404144, 0.10484214127063751, 0.1422654688358307, -0.08844871819019318, 0.014641513116657734, -0.2266954779624939, 0.032735880464315414, -0.05241360142827034, 0.030466072261333466, -0.08616951107978821, -0.051652632653713226, 0.008422312326729298, -0.03688791021704674, 0.008909646421670914, -0.2114546298980713, 0.13078351318836212, -0.04478263109922409, -0.07273468375205994, -0.1638004332780838, 0.2691172957420349, -0.09622234106063843, -0.14621053636074066, 0.1081814393401146, -0.1930164098739624, 0.014226607978343964, -0.16993525624275208, 0.03882431983947754, -0.06303288042545319, 0.12221469730138779, 0.12068724632263184, -0.013641723431646824, 7.525954174977904e-33, 0.010868827812373638, 0.04084990173578262, 0.10360637307167053, 0.05673636496067047, -0.044788531959056854, 0.030002789571881294, 0.010026348754763603, 0.051951371133327484, -0.1579829752445221, -0.0717959851026535, -0.21406422555446625, 0.03387219086289406, -0.08048047125339508, 0.1445114016532898, 0.16205787658691406, -0.07641170918941498, -0.005641976371407509, -0.01972762495279312, -0.03080996870994568, 0.07777240872383118, -0.03541838005185127, -0.03150882199406624, 0.09850473701953888, 0.10193829238414764, 0.12044258415699005, 0.13846716284751892, -0.06547317653894424, -0.05193551257252693, -0.15539322793483734, 0.004470192361623049, -0.10088679194450378, -0.08947290480136871, -0.08725035190582275, 0.04709842801094055, 0.03718609735369682, -0.055644821375608444, -0.10627475380897522, -0.19738604128360748, 0.023209208622574806, 0.08059850335121155, 0.005492016673088074, 0.10005208849906921, 0.05211339518427849, -0.0352778322994709, 0.075779028236866, -0.17279286682605743, -0.06328874081373215, -0.021975819021463394, -0.03340243175625801, 0.10862833261489868, 0.13982129096984863, 0.20566827058792114, 0.12740275263786316, -0.2126724123954773, -0.05756009370088577, 0.044916801154613495, -0.02293025329709053, -0.08249546587467194, 0.06651018559932709, 0.12822198867797852, -0.1725219488143921, 0.01581185683608055, -0.027946986258029938, 0.08451889455318451, 0.09292802959680557, 0.06257519125938416, -0.07273910194635391, -0.05227447301149368, 0.04457246884703636, 0.14148229360580444, 0.13568846881389618, -0.17543065547943115, 0.048113878816366196, -0.14995552599430084, 0.06206938624382019, -0.05659050494432449, 0.06045523285865784, 0.14371007680892944, 0.03076479770243168, -0.05782183259725571, -0.051468800753355026, 0.1607370376586914, -0.12430115044116974, 0.17822754383087158, -0.07616305351257324, -0.07074558734893799, 0.029981421306729317, 0.10753417760133743, -0.015296080149710178, 0.03204670920968056, 0.10093612223863602, 0.07360436022281647, -0.008519891649484634, 0.04357241839170456, -0.04449128732085228, -6.35323178677165e-33, -0.08614841848611832, -0.13772064447402954, -0.11015371978282928, 0.007166222203522921, -0.16333606839179993, 0.053084611892700195, 0.14682404696941376, -0.09217928349971771, 0.07693826407194138, -0.13438841700553894, -0.10894336551427841, 0.09568427503108978, 0.05761456489562988, 0.11058270186185837, -0.10418006032705307, 0.05266355723142624, -0.07673835754394531, -0.043737463653087616, -0.13764236867427826, -0.12066283822059631, 0.045186545699834824, 0.20111383497714996, 0.05796365067362785, -0.012907374650239944, -0.010259401053190231, -0.03249109163880348, -0.005170826800167561, 0.2242564857006073, 0.09452278912067413, -0.046417851001024246, -0.08202756941318512, 0.050422266125679016, 0.014303289353847504, 0.06829841434955597, -0.018804261460900307, -0.07621382176876068, 0.17157110571861267, -0.07503695785999298, 0.24241462349891663, -0.13568294048309326, 0.04530936852097511, -0.0011029485613107681, -0.10980178415775299, 0.07973958551883698, -0.014742734842002392, 0.11354263126850128, 0.14166446030139923, -0.006977634504437447, 0.17142796516418457, 0.1648898422718048, -0.10751451551914215, -0.09221504628658295, -0.024382326751947403, -0.031905122101306915, -0.10480253398418427, -0.11200930178165436, 0.036073364317417145, -0.09819047898054123, 0.03452174738049507, -0.00335385138168931, 0.047835372388362885, -0.03973624110221863, 0.12389868497848511, -0.015226342715322971, 0.13701856136322021, 0.1970525085926056, 0.160635843873024, 0.029410257935523987, -0.014117376878857613, -0.05100148916244507, -0.012018081732094288, 0.09745915234088898, 0.08319366723299026, -0.14285874366760254, 0.03712299466133118, -0.06649638712406158, -0.06111360341310501, -0.0030716732144355774, -0.006501995027065277, 0.0598217248916626, 0.03876812011003494, -0.11097446084022522, 0.05050420016050339, -0.054509714245796204, 0.1759863644838333, 0.11908774077892303, 0.05280343070626259, -0.013663937337696552, -0.03486861661076546, 0.04115401580929756, -0.06746628880500793, -0.11088022589683533, 0.014458014629781246, 0.2272743284702301, -0.10968472063541412, -9.914627696616662e-08, 0.1935780942440033, -0.10320228338241577, -0.020897887647151947, -0.09567058086395264, 0.008779440075159073, 0.09291879832744598, -0.11180996149778366, -0.04341389983892441, 0.1323121190071106, 0.09269643574953079, 0.08156872540712357, 0.08881480991840363, -0.02881818637251854, 0.05647905915975571, 0.016649413853883743, 0.11629451811313629, -0.20119687914848328, 0.084914430975914, -0.15567746758460999, -0.060286685824394226, -0.10109850019216537, 0.07237861305475235, -0.12680669128894806, 0.05768732354044914, 0.10142511129379272, -0.058275267481803894, 0.058160725980997086, 0.013961298391222954, 0.09938058257102966, -0.19747911393642426, -0.13689133524894714, 0.01595940813422203, -0.04663855955004692, 0.011258073151111603, -0.27187269926071167, -0.07794097065925598, 0.06027526408433914, 0.150640070438385, 0.15122926235198975, 0.026240242645144463, 0.05204293131828308, -0.005716321989893913, -0.06913331151008606, -0.11658872663974762, -0.08758823573589325, -0.04827544465661049, -0.25337058305740356, -0.15788903832435608, -0.032258838415145874, 0.03957780823111534, -0.1123058870434761, -0.010598909109830856, 0.01179830078035593, -0.011280829086899757, -0.06504271924495697, 0.03283856809139252, -0.04658747464418411, -0.11234235763549805, 0.2805023789405823, -0.05003776401281357, -0.08611047267913818, -0.1864159107208252, 0.197419673204422, -0.0009365305304527283], "changes": {"1wk": -1.546396377020874}}, {"text": "InTheZoneLabs(R) Nootropic Solutions Prove Transformative for Veterans and First Responders Nitches, inc Wed, Jan 22, 2025, 4:15 PM 3 min read MIAMI, FL / ACCESS Newswire / January 22, 2025 / Nitches Inc. (OTC PINK:NICH) - InTheZoneLabs\u00ae today announced its growing impact within the veteran and first-responder communities, highlighting testimonials from service members who have experienced improved mental clarity, focus, and restorative sleep through the company's nootropic supplements. The brand, which features scientifically backed ingredients like L-theanine, lion's mane mushroom, alpha-GPC, and phosphatidylserine, is dedicated to providing an alternative that may help reduce reliance on certain prescription drugs. Empowering Service Members, One Capsule at a Time Sgt. Erik Wacker (Bronze Star, 2017-Present) offered a powerful testimonial reflecting on his 22 years of active-duty service in the Army, including seven combat deployments to Afghanistan and Iraq: \"Once I got out, everything was in slow motion and I was getting a lot of brain fog. I was then given the opportunity to get InTheZone Focused Extreme . InTheZone has really worked for me and my brain fog is gone-I feel like I am back to myself again. I am focused on my current work in law enforcement and now I am zeroed in again! Thank you InTheZone, you have a lifelong customer!\" GovX Partnership & Discount Acknowledging the exceptional dedication of veterans, first responders, and teachers, InTheZoneLabs\u00ae has integrated with GovX to provide a 30% discount to all members who visit inthezonelabs.com and verify their status. GovX-known for its broad reach across military, law enforcement, firefighter, EMS, and related communities-serves millions of verified members. InTheZoneLabs\u00ae invites all eligible individuals to take advantage of this exclusive offer on its homepage, while also making products available via Amazon and the TikTok Shop . Better Brain Health, Rest, and Performance Backed by a carefully curated formula, InTheZoneLabs\u00ae products are designed to help individuals stay sharp at work, tackle demanding schedules, and unwind more effectively at the end of the day. The brand's commitment to holistic well-being aligns with mounting evidence that natural nootropic ingredients can enhance cognitive performance without the downsides often associated with prescription stimulants. About InTheZoneLabs\u00ae Dedicated to helping everyday heroes and high-achievers alike optimize mental clarity, focus, and resilience, InTheZoneLabs\u00ae provides an array of supplements formulated with proven natural ingredients. By blending science and innovation, the company aims to offer unparalleled support for those who serve our nation and communities. Story Continues FDA Disclaimer These statements have not been evaluated by the Food and Drug Administration. InTheZoneLabs\u00ae products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Forward-Looking Statements: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as \"anticipates,\" \"expects,\" \"intends,\" \"plans,\" \"believes,\" \"seeks,\" \"estimates,\" and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Contact Information John Morgan Ceo info@nitchescorp.com SOURCE: Nitches, inc View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-22T13:15:00+00:00", "sentiment": {"score": 0.5532190203666687, "confidence": 0.5629244446754456, "probabilities": {"positive": 0.5629244446754456, "negative": 0.009705424308776855, "neutral": 0.4273700714111328}}, "embedding": [-0.10653998702764511, -0.03676000237464905, -0.011327007785439491, -0.02673940360546112, 0.11228218674659729, -0.02323778346180916, 0.09049944579601288, 0.11854782700538635, -0.036837805062532425, 0.02396496571600437, -0.0321626253426075, -0.006104646250605583, 0.05770294740796089, 0.05079527944326401, -0.026724090799689293, 0.022560786455869675, 0.1434333622455597, 0.018606068566441536, -0.09570800513029099, 0.011806033551692963, -0.017278805375099182, 0.02518281526863575, 0.11331934481859207, 0.043592385947704315, -0.18435817956924438, 0.13890938460826874, -0.19462454319000244, -0.039703432470560074, -0.12770116329193115, -0.163339301943779, 0.1492936909198761, 0.15576598048210144, 0.026770099997520447, -0.0816267728805542, -0.0014732545241713524, -0.012890050187706947, -0.042126331478357315, 0.11589950323104858, -0.12281627953052521, -0.004066812805831432, -0.05263213813304901, -0.05330493673682213, -0.0003569619730114937, 0.06855879724025726, -0.12062022089958191, -0.1134582906961441, -0.1017531082034111, 0.03297746554017067, -0.0008364771492779255, 0.1465020775794983, -0.10323510318994522, -0.17582722008228302, 0.01376228965818882, 0.08413242548704147, -0.044917672872543335, 0.030521249398589134, -0.12744569778442383, 0.047932885587215424, -0.11781953275203705, 0.06015341728925705, -0.022697007283568382, -0.04309411719441414, -0.04306219518184662, 0.04863487184047699, -0.002933301031589508, 0.1220732182264328, -0.020785382017493248, -0.052059195935726166, -0.04221372678875923, -0.0471034049987793, -0.010199980810284615, -0.04449955001473427, 0.037562672048807144, 0.1058759093284607, 0.006556339096277952, 0.23442856967449188, 0.18986359238624573, -0.0022005299106240273, 0.2113531231880188, -0.10169090330600739, 0.11212314665317535, 0.20645150542259216, 0.06858974695205688, 0.05908546224236488, 0.03978731110692024, -0.03257976844906807, 0.007954408414661884, 0.0990409404039383, 0.060820285230875015, 0.02046515792608261, 0.14026622474193573, 0.03873700648546219, 0.0032373666763305664, -0.06837848573923111, 0.03975450247526169, -0.09472528845071793, -0.05842427909374237, 0.05848231166601181, -0.1767144501209259, 0.07250405848026276, 0.079087033867836, -0.11298976838588715, -0.07942670583724976, -0.11074814945459366, -0.07150214910507202, -0.04645118862390518, 0.04639121890068054, -0.043300457298755646, 0.030377496033906937, 0.06685768067836761, -0.13513398170471191, 0.04754691198468208, -0.0015326873399317265, 0.004399048164486885, -0.07568366080522537, 0.04504038393497467, 0.026007704436779022, 0.037027500569820404, 0.11799707263708115, -0.0559287890791893, 0.0074889278039336205, -0.026734614744782448, 0.02734518051147461, -0.02598654292523861, 0.052779972553253174, 0.047702059149742126, 0.010989153757691383, 1.2270938508459826e-32, -0.06380623579025269, 0.08128336071968079, -0.05000559240579605, 0.009600337594747543, -0.022667547687888145, -0.003095504827797413, -0.04434214532375336, -0.02405500039458275, -0.053620126098394394, 0.01921979896724224, -0.12095599621534348, 0.23385855555534363, -0.0036011184565722942, 0.14657418429851532, -0.05479193478822708, -0.09656816720962524, -0.10414061695337296, 0.05632258206605911, -0.0184562336653471, 0.026938872411847115, -0.01385416742414236, 0.09096388518810272, -0.06362517178058624, 0.028879527002573013, 0.04634644836187363, 0.10204549878835678, -0.047930557280778885, 0.03815528750419617, 0.07987435162067413, 0.02656465768814087, -0.08755908161401749, -0.021879257634282112, -0.014540253207087517, -0.0604962594807148, -0.07346457242965698, -0.006384052336215973, 0.0016417959704995155, -0.1322535127401352, -0.07553897798061371, -0.05299890786409378, -0.09992354363203049, 0.11748941242694855, -0.049307968467473984, 0.052295904606580734, 0.07238851487636566, -0.05243593826889992, -0.056044962257146835, 0.045388929545879364, 0.034860558807849884, -0.03374580293893814, 0.003530813381075859, 0.0024855711963027716, -0.0066971555352211, -0.09362563490867615, -0.1374310404062271, 0.11896282434463501, -0.05096333101391792, -0.0015115989372134209, 0.14726042747497559, -0.042631085962057114, 0.008557653985917568, 0.03373830020427704, -0.04130946844816208, -0.09970372915267944, 0.03201810643076897, -0.08249437808990479, -0.1004658043384552, -0.09786225855350494, -0.05909695476293564, 0.006408418528735638, 0.012552549131214619, 0.03021700121462345, 0.1181759387254715, 0.014535581693053246, 0.00759898591786623, -0.0641404539346695, 0.005410047248005867, 0.06622232496738434, -0.027771467342972755, -0.06610402464866638, 0.058005090802907944, -0.001468028873205185, -0.03276390582323074, 0.08529356867074966, 0.07849599421024323, -0.03138113021850586, 0.04953606426715851, 0.011550899595022202, -0.14089083671569824, -0.09316431730985641, 0.059730567038059235, -0.0569002702832222, 0.03429155424237251, 0.059674132615327835, -0.09166613221168518, -8.658916201451565e-33, -0.022637275978922844, -0.0947999656200409, 0.012508461251854897, 0.07645225524902344, 0.11494628340005875, 0.12912312150001526, 0.12608778476715088, -0.03239165246486664, 0.036523059010505676, -0.04657090827822685, 0.024257678538560867, 0.005009359214454889, -0.07019656896591187, -0.0691891610622406, 0.02789306454360485, -0.062957763671875, -0.03243522346019745, 0.0395033098757267, -0.12546640634536743, -0.035212527960538864, 0.0001861201599240303, 0.17179866135120392, -0.06950066238641739, 0.0530901700258255, -0.028381062671542168, 0.1397901177406311, 0.1306893527507782, 0.12680333852767944, 0.018141068518161774, -0.007606282830238342, -0.024013537913560867, 0.056345563381910324, -0.16199937462806702, -0.08755432069301605, 0.051884956657886505, 0.04806417226791382, 0.009729398414492607, -0.10022994130849838, -0.25221559405326843, -0.08212961256504059, -0.027208492159843445, 0.09444046020507812, -0.0570298470556736, 0.04051397368311882, 0.018363891169428825, 0.006416670046746731, -0.09133972227573395, -0.11569606512784958, -0.08461718261241913, 0.0919497162103653, 0.007165786810219288, -0.02525397017598152, -0.06700333952903748, 0.07198311388492584, -0.01306694932281971, -0.006516731344163418, -0.009753167629241943, -0.1157817542552948, -0.06332041323184967, 0.011184176430106163, 0.0038625230081379414, 0.10481148958206177, -0.08773624897003174, 0.01726854406297207, 0.18099059164524078, -0.02361263707280159, 0.04914233088493347, 0.042045753449201584, -0.03673817589879036, 0.04094386473298073, 0.014362543821334839, 0.0016813427209854126, -0.03401252627372742, -0.1711776852607727, 0.023255059495568275, 0.03620043769478798, 0.01137187797576189, -0.09504076838493347, -0.13795040547847748, -0.0663401409983635, -0.06716445833444595, -0.1181962788105011, 0.0034203932154923677, 0.057871200144290924, 0.03922447934746742, 0.06277885288000107, 0.06135399267077446, 0.0740087702870369, 0.011506455019116402, 0.1631566286087036, -0.05642867833375931, -0.033787548542022705, -0.15135711431503296, 0.19141216576099396, 0.08380179107189178, -1.0030422004092543e-07, 0.10852565616369247, -0.03005499765276909, -0.07977963984012604, 0.06421390175819397, -0.017203034833073616, -0.10690978169441223, -0.050096623599529266, 0.008523348718881607, -0.07670089602470398, 0.17002016305923462, 0.2066938281059265, 0.08187241107225418, -0.043129779398441315, 0.07130809128284454, 0.07359249144792557, 0.057327307760715485, 0.1350616216659546, 0.03193629905581474, -0.11319094896316528, -0.01683257520198822, -0.09460517764091492, 0.0679425373673439, -0.027541667222976685, -0.13549752533435822, 0.05762375891208649, 0.013485697098076344, 0.0016365135088562965, 0.028724614530801773, 0.04496851935982704, 0.04566473513841629, -0.07038988173007965, 0.08465603739023209, -0.0010799590963870287, -0.05023646354675293, -0.058651626110076904, -0.021724995225667953, 0.17637616395950317, 0.03405158221721649, 0.02103850618004799, 0.05877045542001724, -0.08028712868690491, 0.10080434381961823, 0.049870751798152924, 0.03772416710853577, 0.011414526030421257, -0.11005128920078278, -0.028562262654304504, -0.06469858437776566, 0.07172918319702148, -0.08612564951181412, -0.04243979603052139, 0.0330473929643631, -0.08057323098182678, 0.012519121170043945, -0.08412287384271622, -0.03892604634165764, -0.046304650604724884, -0.0068122525699436665, -0.012126229703426361, 0.016896788030862808, 0.04843878746032715, -0.07192297279834747, 0.08532670140266418, 4.187785089015961e-05], "changes": {"1wk": -8.056864754850885}}, {"text": "GOVX Named Entitlement Partner for NASCAR Xfinity Series Race at Phoenix Raceway PR Newswire Mon, Jan 13, 2025, 4:00 PM 5 min read Multi-year agreement positions GOVX as an Official Partner of Phoenix Raceway and establishes the GOVX 200 race PHOENIX , Jan. 13, 2025 /PRNewswire/ -- Phoenix Raceway,\u00a0NASCAR, and GOVX, the online shopping platform exclusively for current and former military, first responders, emergency medical professionals, educators, and other government service personnel, announced today an official multi-year partnership, headlined by an entitlement of the spring\u00a0NASCAR Xfinity Series race held at Phoenix Raceway. The inaugural GOVX 200 will take place March 8 th . The GOVX 200 \"We are beyond excited and honored to partner with NASCAR and Phoenix Raceway to serve as the title sponsor of the GOVX 200,\" said Alan Cole , GOVX CEO. \"Together, we will honor the passion, speed, and dedication that have come to define the sport and continue to connect the GOVX community in new and thrilling ways.\" As Title Sponsor of the GOVX 200, the GOVX brand will be featured prominently throughout the raceway, including on the asphalt, a trackside billboard, track wall, and pit wall signage, safety barrier decals, and more. Additionally, GOVX will have an integrated presence within the Xfinity Series race TV broadcast on The CW. The GOVX 200 is the second race of Phoenix Raceway's March weekend, which begins with the ARCA Menard Series' General Tire 150 on Friday, March 7 , and culminates Sunday, March 9 , with the Shriners Children's 500 NASCAR Cup Series race. Phoenix Raceway will also host NASCAR Championship Weekend October 31-November 2 , and as a part of this Official Partnership, GOVX will receive additional brand exposure throughout the track during this signature event. \"Phoenix Raceway has an unwavering commitment to our veterans, and we're proud to partner with GOVX, which shares that commitment to the men and women who have served our country,\" said Phoenix Raceway President Latasha Causey . \"The 2025 season at Phoenix Raceway is going to be one for the ages, and GOVX will play a major part of it.\" This partnership follows the earlier announcement of GOVX as a new Official Partner of NASCAR. Through this new partnership, GOVX will serve as the Presenting Sponsor and Official Verification Partner of the NASCAR Miltix program, offering discounted race tickets of 20% off or more to NASCAR-owned tracks nationwide, including Phoenix Raceway. Eligible service members will be able to access this benefit through both NASCAR.com and GOVX.com . First responders and other Americans of service will also be eligible to receive the ticket discount offering through the partnership. With an existing membership of over 9.5M , GOVX will help to amplify NASCAR's commitment to this deserving community. Story Continues NASCAR has a long-tenured and deep-seated appreciation for the military and other service personnel through initiatives such as the annual NASCAR Salutes and Troops to the Track programs, a partnership with Honor and Remember and supporting the mission of Sound Off, a nonprofit organization founded to help reduce veteran suicide through free and anonymous mental health support for veterans and service members. Tickets for all events at Phoenix Raceway are on sale now. Fans are encouraged to visit www.phoenixraceway.com to secure their seats while supplies last. ABOUT PHOENIX RACEWAY Home to NASCAR Championship Weekend since 2020, Phoenix Raceway has been the premier motorsports venue in the Southwest since 1964 and hosts two NASCAR race weekends each year. In 2025, the spring event weekend, March 7-9 , kicks off the race season at Phoenix Raceway and features the NASCAR Cup Series, NASCAR Xfinity Series and ARCA Menards Series. Phoenix Raceway will once again host NASCAR Championship Weekend, October 31 \u2013 November 2 . During the action-packed, three-day event, champions will be crowned in the NASCAR Cup Series, NASCAR Xfinity Series, NASCAR CRAFTSMAN Truck Series and ARCA Menards Series West. Phoenix Raceway also hosts a variety of events throughout the year, including concerts, corporate meetings and conferences, charity events, weddings, holiday events, sport and endurance competitions, and driving schools. For more information, visit www.PhoenixRaceway.com and download the new NASCAR Tracks App at www.phoenixraceway.com/nascar-tracks-app/ . ABOUT NASCAR The National Association for Stock Car Auto Racing (NASCAR) is the sanctioning body for the No. 1 form of motorsports in the United States and owner of 14 of the nation's major motorsports entertainment facilities. NASCAR sanctions races in three national series (NASCAR Cup Series\u2122, NASCAR Xfinity Series\u2122, and NASCAR CRAFTSMAN Truck Series\u2122), four international series (NASCAR Brasil Series, NASCAR Canada Series, NASCAR Euro Series, NASCAR Mexico Series), four regional series (ARCA Menards Series, ARCA Menards Series East & West and the NASCAR Whelen Modified Tour) and a local grassroots series (NASCAR Advance Auto Parts Weekly Series). The International Motor Sports Association\u2122 (IMSA\u00ae) governs the IMSA WeatherTech SportsCar Championship\u2122, the premier U.S. sports car series. NASCAR also owns Motor Racing Network, Racing Electronics, and ONE DAYTONA . Based in Daytona Beach, Florida , with offices in five cities across North America , NASCAR sanctions more than 1,200 races annually in 11 countries and more than 30 U.S. states. For more information visit www.NASCAR.com and www.IMSA.com , and follow NASCAR on Instagram, YouTube, TikTok, X and Facebook. ABOUT GOVX GOVX is dedicated to serving those who serve our country and communities \u2013 military service members, first responders, law enforcement officers, emergency medical professionals, educators, and other government service personnel. With a customizable suite of solutions, GOVX provides leading brands who share in our mission with a unique opportunity to support this deserving audience. Through our flagship ecommerce site, GOVX.com, brands can authentically reach a growing community of 9.5M+ members with their own storefront. More than 1K trusted brands currently have a storefront on GOVX.com, offering unbeatable deals to those who serve. With our verification app, GOVX ID, brands can easily enable service member discounts within the checkout flow of their own sites. More than 3K brands currently utilize our GOVX ID technology to honor service members. By leveraging GOVX marketing services solutions, brands can effectively amplify their products or services within our engaged and exclusive community and reinforce their support for Americans who make a difference. In addition to providing unmatched value to those who serve, GOVX also donates a portion of every order to nonprofits who serve the military and first responder community. To-date we have donated more than $1.5M through our GOVX Gives Back initiative. For more information, visit https://www.govx.com . Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/govx-named-entitlement-partner-for-nascar-xfinity-series-race-at-phoenix-raceway-302348461.html SOURCE GOVX View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-13T13:00:00+00:00", "sentiment": {"score": 0.3120981017127633, "confidence": 0.32359158992767334, "probabilities": {"positive": 0.32359158992767334, "negative": 0.01149348821491003, "neutral": 0.6649149060249329}}, "embedding": [-0.0591760128736496, -0.10211020708084106, 0.0065177022479474545, -0.04903172701597214, 0.011744296178221703, 0.10466167330741882, 0.03680194169282913, -0.016597267240285873, 0.0007051229476928711, -0.054258815944194794, -0.1618518829345703, 0.06349601596593857, 0.03377898782491684, 0.09177655726671219, 0.031377632170915604, -0.2205621302127838, 0.18351614475250244, -0.10196437686681747, 0.007260113954544067, 0.14749398827552795, 0.3215551972389221, -0.1863355040550232, -0.06818433105945587, 0.024940067902207375, -0.14214330911636353, 0.074835866689682, -0.14889776706695557, 0.0531928651034832, -0.06547445058822632, 0.05127115547657013, 0.0777442455291748, 0.12848450243473053, 0.04310053586959839, -0.09348754584789276, 0.031284868717193604, -0.07734560966491699, 0.027630694210529327, -0.08670803904533386, -0.04914738982915878, -0.06617370247840881, 0.14561709761619568, -0.11956454813480377, -0.15175506472587585, 0.06587766110897064, 0.0938766598701477, -0.03325020521879196, 0.09201927483081818, 0.022041911259293556, 0.07356727123260498, 0.03717377409338951, 0.0008896663784980774, -0.12493428587913513, 0.20148983597755432, -0.04274221509695053, 0.059119343757629395, 0.12176103889942169, -0.08564604818820953, -0.03519854322075844, -0.05004027858376503, -0.10363125801086426, 0.00212289672344923, -0.10679470002651215, -0.1024017184972763, 0.07740861177444458, -0.07210950553417206, -0.015324334613978863, -0.04052869603037834, -0.009758543223142624, -0.030533671379089355, -0.0944928377866745, 0.03524629771709442, -0.023711565881967545, -0.06002240628004074, 0.04469543695449829, 0.02410140447318554, 0.20710037648677826, 0.12884095311164856, -0.03146028146147728, 0.039774321019649506, -0.28316378593444824, -0.007627431303262711, -0.022382698953151703, 0.15639428794384003, -0.08066705614328384, -0.01175087969750166, -0.02117365412414074, 0.16485774517059326, 0.06335622072219849, 0.03849468007683754, -0.06977169215679169, -0.1833115816116333, 0.08598634600639343, 0.12199918925762177, -0.11746208369731903, 0.02094118669629097, 0.1232667863368988, -0.045057088136672974, -0.04051873832941055, 0.1118403971195221, 0.09261944890022278, 0.07488832622766495, 0.05242649465799332, -0.06744501739740372, 0.04754945635795593, -0.0648157075047493, 0.0022166497074067593, -0.17729657888412476, 0.06410760432481766, -0.008877638727426529, -0.03729361295700073, 0.03644787147641182, 0.04686417058110237, 0.0909065529704094, -0.040019597858190536, -0.16025316715240479, 0.2690519094467163, -0.1267131268978119, 0.1089659035205841, 0.2370862364768982, -0.051801636815071106, -0.09678960591554642, -0.03347647562623024, -0.008975477889180183, 0.15934434533119202, 0.2804998755455017, -0.029956642538309097, -0.0947343111038208, 3.819685139024527e-33, -0.2161581814289093, 0.02880757674574852, -0.005852111149579287, -0.15728634595870972, 0.0084633007645607, 0.10186880826950073, 0.14572995901107788, -0.08926855027675629, -0.07332275807857513, -0.0073273926973342896, -0.08154086023569107, 0.1728089153766632, -0.006165645085275173, 0.018604207783937454, 0.02089511975646019, -0.09743741899728775, -0.139143705368042, -0.04946444183588028, -0.1684413105249405, 0.09167557209730148, 0.06083112955093384, 0.011710498481988907, -0.045996613800525665, -0.015782490372657776, 0.07309024035930634, 0.1676795482635498, -0.024893105030059814, -0.09720909595489502, 0.17147380113601685, 0.0734102725982666, -0.1380465179681778, -0.06542804837226868, 0.12457306683063507, 0.057515114545822144, -0.10236476361751556, 0.00147189199924469, -0.05728209391236305, -0.0954388678073883, -0.017811795696616173, -0.016014762222766876, -0.015322243794798851, -0.06158345937728882, -0.0048590973019599915, -0.17829322814941406, -0.1917443424463272, 0.023653708398342133, 0.07720170170068741, 0.0022086715325713158, 0.04903162643313408, -0.0008401349186897278, 0.09693858027458191, -0.030416805297136307, -0.026290083304047585, -0.11837463080883026, -0.13598008453845978, 0.07555506378412247, -0.01636602357029915, -0.06154976412653923, -0.10721635818481445, -0.04637165367603302, -0.014734417200088501, -0.07037485390901566, -0.10294190049171448, 0.025776948779821396, -0.15297365188598633, 0.1613285094499588, 0.18341919779777527, 0.02182568609714508, -0.1269562840461731, 0.17793555557727814, -0.1160920187830925, 0.08303479105234146, -0.020717773586511612, 0.030605493113398552, 0.07801765948534012, -0.004825612064450979, 0.06254106760025024, 0.0721108615398407, -0.07759000360965729, 0.15429463982582092, -0.14246517419815063, -4.7795940190553665e-05, 0.12274987995624542, -0.012741182930767536, 0.015765508636832237, -0.10524924844503403, 0.041746724396944046, 0.20419833064079285, 0.11275628209114075, -0.07602725178003311, 0.00458776019513607, -0.10765363276004791, 0.06400890648365021, 0.30578410625457764, -0.027992699295282364, -4.745753914939726e-33, -0.04286333918571472, -0.047587327659130096, 0.04919704049825668, 0.06881610304117203, 0.01443558931350708, 0.03642610087990761, 0.18517394363880157, -0.10565374791622162, 0.0719037875533104, -0.06648291647434235, 0.05027506873011589, 0.030028551816940308, -0.02210971713066101, 0.032226838171482086, -0.13071735203266144, -0.12634983658790588, 0.02383231930434704, 0.03172214701771736, -0.1288878172636032, -0.07815643399953842, 0.016793811693787575, 0.17477314174175262, -0.11422693729400635, -0.01255381666123867, 0.09544423222541809, -0.04547137767076492, 0.1624910533428192, 0.06410109251737595, 0.003515394404530525, -0.00939854048192501, -0.14870834350585938, -0.05729569494724274, -0.19909703731536865, 0.009591542184352875, 0.015121023170650005, 0.057031914591789246, -0.024912700057029724, -0.08290466666221619, -0.1087496429681778, 0.07102836668491364, 0.11003629863262177, -0.005943126045167446, 0.10384388267993927, 0.11609376966953278, -0.00693830382078886, 0.02227511629462242, 0.013680619187653065, -0.10336888581514359, 0.015471773222088814, 0.20457741618156433, -0.0979025810956955, -0.04067901521921158, -0.07100444287061691, 0.11725643277168274, -0.11920715868473053, 0.0053117601200938225, 0.07297533750534058, 0.1614668369293213, -0.14043331146240234, 0.057271696627140045, 0.12572696805000305, 0.08856594562530518, 0.03595280647277832, 0.08237717300653458, 0.11494922637939453, -0.11403050273656845, -0.05050772428512573, -0.15553757548332214, -0.05374956503510475, 0.09043045341968536, -0.05180462449789047, 0.02598399668931961, -0.26025667786598206, 0.003690382931381464, -0.13092920184135437, 0.2536994516849518, -0.013479303568601608, 0.0515962615609169, -0.01768328994512558, -0.0570797398686409, 0.030770843848586082, 0.033555299043655396, 0.05323617532849312, 0.06322775781154633, 0.18067295849323273, 0.1926572173833847, 0.01731552556157112, 0.10798219591379166, 0.08461010456085205, -0.04928212612867355, 0.009080911055207253, 0.0008086998714134097, -0.016356956213712692, 0.10877475142478943, -0.11470870673656464, -9.93862627751696e-08, 0.0002003619447350502, 0.1704789698123932, -0.19252201914787292, -0.039927978068590164, 0.11091287434101105, -0.009869572706520557, 0.008861631155014038, -0.19064998626708984, -0.09711593389511108, -0.008884303271770477, 0.2648668587207794, -0.13737183809280396, -0.06703729927539825, -0.0645768865942955, 0.00503982650116086, 0.027880871668457985, -0.11064991354942322, -0.034072279930114746, -0.05828017741441727, -0.09222957491874695, -0.2449142336845398, -0.0640561506152153, -0.04251161217689514, 0.1116224005818367, -0.03231487423181534, -0.12130342423915863, 0.0329035148024559, 0.2215927541255951, 0.1609402596950531, 0.020212750881910324, -0.11990100145339966, -0.011210586875677109, -0.08212251961231232, 0.006829271093010902, 0.06599624454975128, -0.02558854967355728, -0.07300642132759094, 0.2531852126121521, 0.26917147636413574, 0.11200885474681854, 0.06550826132297516, -0.10871392488479614, -0.01942121610045433, -0.08236407488584518, 0.06507479399442673, 0.032356854528188705, -0.12036232650279999, -0.17363977432250977, 0.16760998964309692, -0.1382206678390503, -0.013213773258030415, -0.08702327311038971, -0.019974777474999428, -0.013655871152877808, 0.02111976593732834, 0.0507272407412529, -0.0911627784371376, -0.1271357536315918, 0.10644488036632538, -0.03537789359688759, -0.023057207465171814, -0.07850420475006104, 0.08168711513280869, 0.07501260936260223], "changes": {"1wk": 4.716988134401508}}, {"text": "GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial NewMediaWire Wed, Jan 15, 2025, 5:00 PM 4 min read In This Article: GOVX -7.33% GOVXW -22.92% Represents a Key Step Toward Validating Gedeptin Potential in Solid Tumor Therapy ATLANTA, GA - January 15, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing innovative immunotherapies and vaccines for cancer and infectious diseases, announced significant progress in advancing Gedeptin as a cancer therapy. Gedeptin, based on a Gene-Directed Enzyme Prodrug Therapy (GDEPT) platform, employs a targeted approach to deliver therapeutic agents directly to tumor sites. The result of this approach is the localized production of a potent anti-cancer agent(s) within the tumor microenvironment, while minimizing systemic exposure and the potential for associated side effects. Following a review of the data from the completed Phase 1 single-cycle and Phase 1/2 multi-cycle Gedeptin trials among patients with advanced Head & Neck (H&N) tumors, GeoVax has decided to initiate a Phase 2 clinical study, evaluating neoadjuvant Gedeptin therapy in combination with an approved immune check point inhibitor (ICI) in 1st recurrent H&N cancer scheduled for resection with curative intent. Therapy Potential and Market Opportunity Gedeptin has been granted Orphan Drug Designation by the U.S. FDA for the intratumoral treatment of anatomically accessible oral and pharyngeal cancers, underscoring its potential to address significant unmet medical needs. \"Preclinical data suggest that Gedeptin/fludarabine can enhance the activity of ICIs in treatment of solid tumors. Our upcoming Phase 2 trial will investigate this approach as a neoadjuvant therapy for patients with first recurrence head and neck cancer. We believe this will lead to increased tumor response and decreased recurrence rates in these patients,\" said David Dodd, Chairman and CEO of GeoVax. \"Based on the data generated to date, this combination has the potential to address multiple solid tumor indications, and represents a significant medical and commercial opportunity, if approved.\" David Dodd added, \"We are entering an exciting phase of clinical development with Gedeptin, and our team remains committed to advancing this innovative therapy to deliver life-changing benefits for cancer patients worldwide.\" Advancing Clinical Development The upcoming Phase 2 trial will evaluate the efficacy of Gedeptin in combination with ICIs in patients with first-recurrence head and neck cancer. Key endpoints will include pathologic response rates and overall treatment outcomes. GeoVax plans to initiate trial activities mid-year and partner with leading academic oncology centers. Story Continues A Transformative Year Ahead GeoVax projects significant milestones in 2025, with Gedeptin expected to play a key role in delivering transformative cancer therapies. Beyond head and neck cancers, the company plans to explore Gedeptin's potential applications across other solid tumor types. GeoVax's CEO, David Dodd, will present the Company's 2024 progress and outlook for 2025 at the Emerging Growth Conference : January 16, 2025, at 2:35 PM ET. For more information on GeoVax's portfolio and developments, please visit www.geovax.com . About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com . Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words \"believe,\" \"look forward to,\" \"may,\" \"estimate,\" \"continue,\" \"anticipate,\" \"intend,\" \"should,\" \"plan,\" \"could,\" \"target,\" \"potential,\" \"is likely,\" \"will,\" \"expect\" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: Investor Relations Contact: Media Contact: info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com 678-384-7220 212-698-8696 202-779-0929 View the original release on www.newmediawire.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-15T14:00:00+00:00", "sentiment": {"score": 0.8943274011835456, "confidence": 0.9045024514198303, "probabilities": {"positive": 0.9045024514198303, "negative": 0.010175050236284733, "neutral": 0.0853225365281105}}, "embedding": [-0.004071802832186222, -0.11098279803991318, 0.003781320992857218, -0.21654999256134033, -0.044279202818870544, -0.09244222939014435, 0.04280730336904526, 0.0684509426355362, 0.12963029742240906, 0.004773331806063652, -0.1239209771156311, 0.13029146194458008, 0.17369435727596283, 0.1345311552286148, -0.06701134890317917, 0.05083492770791054, 0.03715413808822632, -0.006438976153731346, 0.007448146119713783, 0.13323163986206055, 0.059697724878787994, -0.04481629282236099, 0.06079991161823273, 0.04586142301559448, -0.1402122676372528, -0.026229530572891235, -0.1147691160440445, -0.09145110100507736, -0.16309137642383575, 0.05181229114532471, 0.08534667640924454, 0.013033289462327957, -0.16834884881973267, -0.036559391766786575, -0.13609907031059265, 0.037649448961019516, -0.12378962337970734, 0.15814301371574402, -0.08605557680130005, 0.03087026998400688, -0.028802717104554176, 0.01655326411128044, -0.06743820756673813, 0.017178021371364594, 0.20068472623825073, -0.12684358656406403, -0.14633981883525848, -0.09829449653625488, -0.017677608877420425, 0.20623211562633514, -0.051660869270563126, -0.1318756341934204, -0.054005175828933716, 0.1390550285577774, -0.01720334403216839, 0.07335992157459259, -0.12749135494232178, -0.04287900775671005, 0.05978143587708473, 0.10006994754076004, -0.03022039867937565, -0.21103201806545258, 0.061187323182821274, -0.042266085743904114, 0.11496814340353012, -0.02161896973848343, 0.03769221901893616, -0.009731922298669815, -0.13028010725975037, -0.07454746961593628, 0.0024406109005212784, 0.057166390120983124, -0.0025564883835613728, 0.02634461224079132, -0.05389507859945297, 0.031469158828258514, 0.15220120549201965, 0.18081535398960114, 0.13186603784561157, 0.007360588293522596, 0.08006595075130463, 0.21682503819465637, 0.17728133499622345, 0.11352165043354034, -0.010779180563986301, -0.011112146079540253, 0.008741121739149094, 0.1829357147216797, 0.05103575810790062, 0.04864988103508949, 0.17260323464870453, 0.12292586266994476, -0.02383369952440262, 0.03473254665732384, 0.0818239152431488, -0.09754727780818939, -0.14915136992931366, -0.03959163278341293, 0.1284017264842987, -0.001281561329960823, 0.05763370171189308, -0.1956947147846222, -0.050353892147541046, -0.1503404676914215, 0.0563083253800869, -0.038668643683195114, 0.0072802528738975525, 0.03261259198188782, -0.02798338234424591, -0.006365606561303139, -0.08079277724027634, 0.0802689641714096, 0.056934088468551636, -0.02555277943611145, -0.08978958427906036, 0.26454758644104004, -0.0702425166964531, 0.026037566363811493, 0.0883156806230545, -0.09642834961414337, 0.07988402247428894, -0.08010214567184448, -0.025255655869841576, -0.07993599772453308, 0.09190713614225388, 0.08148227632045746, -0.07055118680000305, 9.189082520771648e-33, 0.02562224678695202, -0.07863365858793259, 0.12461332231760025, 0.08888895064592361, -0.04575011134147644, 0.10119253396987915, -0.04597678780555725, 0.07149472832679749, -0.13140423595905304, -0.11762674152851105, -0.059091344475746155, 0.003283236175775528, -0.06437156349420547, 0.16961421072483063, -0.07877232879400253, -0.00805085152387619, -0.03532201796770096, 0.013629850000143051, -0.08213599026203156, -0.14228494465351105, 0.07569366693496704, 0.019808493554592133, 0.04032881557941437, 0.03703838586807251, -0.033840276300907135, 0.10119796544313431, -0.15337735414505005, 0.07717146724462509, -0.01575077697634697, -0.04959796369075775, -0.13237160444259644, -0.07731711864471436, 0.07371021807193756, 0.0878240242600441, -0.13785400986671448, -0.03256405517458916, -0.005735743325203657, -0.17524763941764832, 0.0734773501753807, 0.03848801925778389, -0.03432777523994446, 0.10863640904426575, 0.015560836531221867, -0.08909711241722107, 0.09808647632598877, -0.08821836113929749, -0.043070100247859955, -0.04016970843076706, -0.012284619733691216, 0.09858230501413345, 0.045694541186094284, 0.024268170818686485, -0.11652916669845581, 0.047673843801021576, -0.09742816537618637, 0.09519589692354202, -0.17947548627853394, 0.0845644474029541, 0.1900869607925415, 0.13266462087631226, 0.0031742816790938377, -0.017998699098825455, -0.042465269565582275, -0.035071421414613724, 0.0022797752171754837, 0.09709908068180084, 0.015940850600600243, -0.01454146858304739, -0.05778034031391144, 0.17151111364364624, 0.03494331240653992, 0.01720910146832466, 0.21923132240772247, 0.14769209921360016, 0.08011673390865326, -0.11797575652599335, 0.12444785237312317, 0.05377573519945145, 0.049530450254678726, 0.1450660228729248, -0.0466424822807312, 0.041302356868982315, -0.22660163044929504, 0.19184380769729614, -0.06622285395860672, -0.12964372336864471, -0.002004893496632576, -0.09950388222932816, -0.1445789337158203, 0.05054040253162384, 0.06634428352117538, -0.030502207577228546, -0.07961422950029373, 0.06190909445285797, -0.02273591235280037, -1.0756055428668128e-32, -0.010477159172296524, -0.06576155126094818, 0.01413328293710947, 0.0021254923194646835, -0.01077406108379364, 0.11674851179122925, 0.040151067078113556, -0.1048106849193573, 0.050234995782375336, -0.13988728821277618, 0.01867992803454399, 0.11251720786094666, 0.05906291306018829, 0.09783990681171417, -0.10331308841705322, -0.072468101978302, -0.06756992638111115, -0.08499613404273987, -0.14867249131202698, 0.06607173383235931, 0.17442333698272705, 0.2199166715145111, -0.09587529301643372, -0.05713469535112381, 0.03321635723114014, -0.0317130871117115, 0.11388950049877167, 0.15709319710731506, 0.06521636247634888, 0.12474590539932251, -0.14286264777183533, 0.06179789826273918, -0.19915419816970825, -0.052182674407958984, 0.037198618054389954, -0.05603259801864624, 0.15664762258529663, -0.18566742539405823, -0.09005878120660782, -0.12330251932144165, -0.008230873383581638, -0.08278641104698181, 0.029515620321035385, 0.023213908076286316, 0.03205544874072075, 0.1957060545682907, 0.04529069364070892, 0.0903804749250412, 0.14166195690631866, 0.09283491969108582, -0.10299011319875717, 0.007431458681821823, -0.053160980343818665, -0.07846743613481522, -0.021526772528886795, -0.09223800897598267, -0.018881238996982574, -0.08904295414686203, 0.007124782539904118, -0.02345868945121765, -0.026766080409288406, 0.04062169790267944, 0.008336213417351246, -0.019380707293748856, 0.00025929510593414307, 0.2000914216041565, 0.11913011968135834, 0.058449886739254, 0.11212727427482605, -0.040482297539711, -0.17888174951076508, 0.014704259112477303, 0.07070480287075043, -0.17213237285614014, -0.01566857099533081, 0.11533011496067047, 0.019120480865240097, -0.1310548037290573, -0.04605560004711151, -0.04659227281808853, 0.035302840173244476, 0.01973118633031845, 0.00021357019431889057, -0.10549597442150116, 0.15555012226104736, 0.18662898242473602, -0.005728640127927065, 0.00681853573769331, -0.0021423138678073883, 0.022169282659888268, -0.09083694964647293, -0.043167777359485626, -0.06286665797233582, 0.053427524864673615, -0.19054058194160461, -1.002515688242056e-07, 0.023172833025455475, -0.10620991140604019, 0.061740413308143616, -0.17181044816970825, -0.05993172153830528, -0.013846687972545624, -0.050995975732803345, -0.07923652231693268, -0.10525782406330109, 0.08652061223983765, 0.13496758043766022, 0.15133260190486908, -0.1252523809671402, -0.12411381304264069, -0.09056803584098816, -0.0038217762485146523, -0.03359932452440262, 0.03477894887328148, -0.08672536909580231, -0.06038083881139755, -0.14277054369449615, 0.040204599499702454, -0.045608893036842346, -0.01656244322657585, 0.08403457701206207, -0.15293332934379578, 0.0635121762752533, 0.16441649198532104, 0.04859832674264908, -0.2092210352420807, -0.0668313205242157, -0.004498634487390518, 0.011902352795004845, 0.040827494114637375, -0.027198676019906998, -0.023874999955296516, -0.05492120236158371, 0.10635492205619812, 0.16902178525924683, -0.0031714746728539467, 0.045651569962501526, 0.036725785583257675, -0.039748191833496094, -0.06908196210861206, -0.12831683456897736, -0.017880583181977272, -0.011391248553991318, -0.04464001581072807, 0.07517527043819427, -0.10525524616241455, -0.006248575635254383, -0.05148495361208916, -0.042370639741420746, -0.029860366135835648, -0.043836213648319244, 0.19769877195358276, -0.03833062946796417, -0.1345752626657486, 0.12029868364334106, -0.04909101873636246, -0.10654931515455246, -0.19580432772636414, 0.11028791964054108, -0.04457448795437813], "changes": {"1wk": -1.3333320617675781}}, {"text": "Apollo Neuro Partners with GOVX to Better Serve Those Who Serve Us PR Newswire Tue, Jan 14, 2025, 11:20 PM 3 min read PITTSBURGH , Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest partnership with GOVX , an e-commerce platform that offers exclusive deals for educators, first responders, medical professionals, Veterans and active military, and other eligible government workers. Apollo Neuroscience was created by a team of neuroscientists and physicians and co-founded by Dr. Dave Rabin, MD. PhD. This partnership reflects our continued commitment to offering life-changing technology that improves both mental and physical health. Apollo Neuroscience joins brands like Oura, Oakley, YETI, Crocs, NFL Tickets, and Vuori on the GOVX platform to offer useful discounts to individuals who deserve recognition for their hard work. Special Offer for GOVX Members: On GOVX, Apollo Neuroscience is offering up to 20% off Apollo wearables and accessories for this incredible group of individuals who demand the best of themselves in their day-to-day duties to help their community achieve great things. To access the Apollo\u00a0Neuro discount via GOVX, visit: https://apolloneuro.com/pages/everyday-heroes , and click Verify Now. Apollo Neuro's Continued Commitment to Support the Mission The Apollo wearable is the No. 1 doctor-recommended wearable stress relief tool for those in high-stress roles. Apollo calms the storm of the fight-or-flight response by nurturing the parasympathetic nervous system, governed by the Vagus nerve, training stress resiliency and recovery. Apollo vibrations are designed to feel like a warm hug or snuggling a pet, naturally enhancing nervous system balance that is disrupted by chronic stress and trauma. Developed by Dr. David Rabin , MD, PhD, a psychiatrist and neuroscientist, while working with and treating veterans, the Apollo wearable has won over 15 product and innovation awards for being the first wearable technology to deliver on the promise of significantly improved sleep, stress resiliency, calm, and energy. The Apollo wearable is a small device that can be worn discreetly anywhere on the body, over or under clothing, with a strap or clip. \"We wouldn't have been able to invent the Apollo wearable without the veteran community. Working with veterans and their families for years as a psychiatrist taught me how important it is to feel safe and in control at any moment, especially when trying to fall asleep,\" said Dr. Rabin. \"Techniques like meditation and deep breathing help, but they are really hard to do when we're already stressed and exhausted. Technology can now make relaxation and recovery easy wherever we are, and we couldn't be more proud to bring Apollo Neuro into the world as the first wellness wearable to accomplish this for those who have dedicated their lives to protecting us and our country.\" Story Continues Dr. Rabin and his team have been collaborating with veterans and active-duty military to design technology that improves their lives since 2016. Dr. Rabin has been working with Ret. Major General T. S. Jones and serves on the board of Semper Fi Odyssey and Outdoor Odyssey, founded by General Jones, to develop programs to help veterans and active-duty service members recover from trauma. \"The impact was immediately recognized, especially for its calming effect and for the ability to help one sleep,\" General Jones said of his experience with Apollo over the last four years. \"The Apollo device naturally augments our work with warriors, as the vast majority at this juncture struggle with stress-related issues.\" Additional references regarding the science that powers Apollo Neuro : https://apolloneuro.com/pages/science https://apolloneuro.com/blogs/news/the-biology-of-stress https://apolloneuro.com/pages/studies-roundup PRESS CONTACT Ava D'Ambrosio ava@stanton-company.com 949-533-7501 Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/apollo-neuro-partners-with-govx-to-better-serve-those-who-serve-us-302350933.html SOURCE Apollo Neuroscience View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-14T20:20:00+00:00", "sentiment": {"score": 0.3161808727309108, "confidence": 0.32532259821891785, "probabilities": {"positive": 0.32532259821891785, "negative": 0.009141725488007069, "neutral": 0.6655356884002686}}, "embedding": [-0.21960997581481934, -0.007281087338924408, 0.04702875390648842, -0.019537154585123062, -0.0018591247498989105, -0.08872701972723007, 0.18589302897453308, 0.08143462985754013, -0.008271396160125732, 0.09407355636358261, -0.05961684137582779, 0.03666176274418831, -0.07099439203739166, 0.11774726212024689, 0.0433741919696331, -0.009943806566298008, 0.08567395806312561, 0.06140342354774475, -0.09061095118522644, 0.1797788143157959, 0.015183093026280403, -0.032882243394851685, -0.037697434425354004, 0.06933066248893738, -0.14102496206760406, 0.15331268310546875, -0.15750062465667725, -0.1174212098121643, -0.04531330242753029, 0.010404474101960659, 0.003131592646241188, 0.022524911910295486, -0.09646239876747131, -0.007565194275230169, -0.1715574562549591, 0.0647902637720108, -0.06240636855363846, -0.09888695925474167, -0.15800949931144714, -0.03250540420413017, -0.11454268544912338, -0.003767454531043768, -0.13064195215702057, 0.04313694313168526, -0.04143349826335907, -0.05792783573269844, 0.05078218877315521, -0.0688396692276001, 0.040285367518663406, -0.022202225401997566, -0.05700783431529999, -0.05524204298853874, 0.08294342458248138, 0.06895574927330017, 0.011287817731499672, 0.11084400117397308, -0.20220905542373657, -0.07760535925626755, -0.11004757136106491, -0.06062953919172287, -0.05134483426809311, 0.042166560888290405, 0.03210185095667839, 0.03593212366104126, 0.01518528163433075, 0.1943054497241974, -0.08452858030796051, -0.10919105261564255, 0.05558856576681137, -0.07766109704971313, 0.006368410307914019, -0.11526088416576385, 0.032796844840049744, 0.030841711908578873, 0.045438431203365326, 0.09220326691865921, 0.11710698902606964, 0.038602568209171295, 0.11590395867824554, -0.12983311712741852, 0.06710141897201538, -0.002559487707912922, -0.059573695063591, 0.10576675832271576, 0.09979929029941559, -0.03876912593841553, -0.020910397171974182, 0.06808456778526306, 0.005971086211502552, -0.09163463115692139, -0.010057920590043068, 0.07134966552257538, -0.042770303785800934, -0.1590452343225479, 0.0987904742360115, 0.00157186109572649, -0.09820926934480667, 0.0805647000670433, -0.0794529914855957, 0.07010246813297272, 0.07928779721260071, 0.13101354241371155, 0.01690404675900936, 0.06247933954000473, -0.020997118204832077, -0.08416662365198135, -0.04733725264668465, -0.11980132758617401, 0.06864414364099503, 0.09022168815135956, -0.0950685441493988, 0.05672481656074524, 0.02432830259203911, -0.01885395310819149, -0.07148327678442001, 0.12834131717681885, -0.29840734601020813, 0.11740213632583618, 0.2873091399669647, -0.015915295109152794, 0.04620758071541786, -0.08814793825149536, -0.07446351647377014, -0.12220891565084457, -0.0017415257170796394, 0.0025502387434244156, -0.14092224836349487, 6.569296464660417e-33, -0.04755620285868645, 0.14030446112155914, 0.044795431196689606, -0.1323505938053131, 0.03846726566553116, 0.05087120831012726, -0.041137151420116425, 0.001979006454348564, -0.033914726227521896, 0.05114665627479553, -0.12095606327056885, 0.1403467059135437, 0.032441020011901855, 0.15271644294261932, 0.11873132735490799, -0.014178594574332237, -0.1515321135520935, -0.06205315515398979, 0.06217515468597412, 0.0017160465940833092, 0.007469736039638519, -0.02331523597240448, -0.06080024316906929, 0.11728589981794357, 0.08938776701688766, 0.06289446353912354, -0.10936982929706573, 0.12463685870170593, 0.053315214812755585, 0.04970041662454605, -0.1849484145641327, 0.022200189530849457, 0.07577936351299286, -0.17210954427719116, -0.09706655144691467, -0.031469233334064484, -0.06583870947360992, -0.06546755135059357, -0.0036620486062020063, -0.03631489723920822, 0.07076862454414368, 0.1307518482208252, 0.0005806116387248039, -0.03484209254384041, -0.03315068781375885, 0.026953469961881638, 0.07874588668346405, 0.002899507526308298, -0.005197383463382721, -0.05634574592113495, -0.005215806886553764, -0.021219497546553612, 0.004992109257727861, -0.19022560119628906, -0.05409596860408783, -0.0627770870923996, 0.058554813265800476, -0.004211736377328634, -0.03228481113910675, 0.07261687517166138, -0.06635536253452301, -0.08038895577192307, 0.03903615102171898, 0.03303825110197067, 0.046657711267471313, 0.08249583840370178, -0.02025623992085457, -0.00045718345791101456, -0.12225906550884247, -0.007960844784975052, -0.10048583894968033, 0.11253944784402847, 0.021924125030636787, -0.13376496732234955, -0.010404755361378193, -0.04192497208714485, 0.0552082285284996, -0.041651394218206406, -0.11217260360717773, -0.11476323008537292, -0.06316039711236954, -0.030737219378352165, -0.03437275439500809, 0.17336344718933105, 0.15581676363945007, -0.05392301827669144, 0.05734620243310928, 0.020813647657632828, -0.14754320681095123, -0.0920010507106781, 0.10118751972913742, -0.07732710242271423, 0.061990104615688324, 0.10811060667037964, -0.10296021401882172, -7.628731319490143e-33, -0.0877625048160553, -0.13236191868782043, 0.03429926559329033, 0.024134159088134766, 0.14617539942264557, 0.014639717526733875, 0.09497085213661194, -0.061780765652656555, -0.04255898296833038, 0.006102174520492554, 0.03680703788995743, -0.030817054212093353, -0.11558277904987335, 0.05324992537498474, 0.02600403130054474, 0.019392142072319984, -0.15164291858673096, 0.08240916579961777, -0.03023747354745865, -0.02269839681684971, 0.23887166380882263, 0.32581406831741333, -0.031845755875110626, 0.0679478645324707, -0.0570480041205883, 0.015224972739815712, 0.05099097639322281, 0.0703207403421402, 0.05780695751309395, -0.00886942446231842, -0.07393220067024231, 0.011086146347224712, -0.222741037607193, -0.07248573005199432, 0.13456392288208008, 0.15280625224113464, 0.08829745650291443, -0.08789347857236862, -0.022318586707115173, -0.09475790709257126, 0.11382134258747101, 0.1057441309094429, 0.037864599376916885, 0.057504843920469284, 0.07612348347902298, 0.03379817679524422, -0.0922592356801033, -0.05401668697595596, -0.2563153803348541, 0.020305149257183075, -0.021667230874300003, -0.11954481899738312, -0.08200043439865112, -0.057308439165353775, -0.12002916634082794, 0.03707901015877724, -0.10564002394676208, -0.0036153397522866726, 0.04203558713197708, -0.12665429711341858, -0.02671675570309162, 0.0021084435284137726, -0.040862008929252625, 0.09104115515947342, -0.031472302973270416, 0.08822563290596008, 0.04555826634168625, 0.08622540533542633, -0.026878569275140762, 0.11261054873466492, -0.11275790631771088, -0.038643188774585724, 0.02229030802845955, 0.056530166417360306, 0.026295967400074005, 0.14409002661705017, -0.04294232651591301, 0.002254895865917206, 0.004930069670081139, 0.011379699222743511, -0.06746985763311386, -0.0808633342385292, 0.05371168255805969, -0.0011188853532075882, 0.0675516426563263, 0.1909540742635727, -0.048938825726509094, 0.13465073704719543, -0.08445718884468079, 0.03133120760321617, -0.04020162299275398, -0.014235759153962135, -0.07036291062831879, 0.13886307179927826, -0.024605516344308853, -1.0001910766277433e-07, 0.018272697925567627, -0.013449124991893768, 0.04260753095149994, -0.026194216683506966, 0.08631736785173416, -0.035781580954790115, 0.10411638021469116, -0.026640186086297035, -0.12952110171318054, 0.12126171588897705, 0.10731599479913712, 0.03946197032928467, -0.025963589549064636, 0.049340199679136276, 0.013084947131574154, 0.2510850429534912, -0.05322384089231491, 0.11606264114379883, -0.07855142652988434, -0.07203327864408493, 0.03016405552625656, -0.039001114666461945, 0.0922548696398735, 0.04040752723813057, 0.15162667632102966, -0.10220028460025787, 0.1007838100194931, 0.11305657029151917, -0.03834039717912674, 0.05116001516580582, -0.06328930705785751, -0.0940750241279602, 0.04779350012540817, -0.019215237349271774, 0.025387480854988098, -0.1423451453447342, 0.1246013417840004, -0.0408700630068779, 0.09905759990215302, 0.03282216563820839, -0.003271878696978092, -0.010802863165736198, -0.08327364921569824, 0.10625448077917099, 0.0758291631937027, -0.09683921188116074, 0.022742221131920815, -0.004378313198685646, 0.03130345419049263, -0.016049031168222427, -0.026477662846446037, -0.09367500245571136, -0.0004714932292699814, -0.13091886043548584, -0.12007951736450195, -0.018258672207593918, -0.07723040878772736, 0.09582285583019257, 0.03342344984412193, -0.049912892282009125, 0.1120588630437851, 0.015399345196783543, -0.0681193470954895, 0.03414735198020935], "changes": {"1wk": 5.213276729068684}}, {"text": "GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024 NewMediaWire Mon, Jan 13, 2025, 5:00 PM 6 min read In this article: GOVX -7.33% GOVXW -22.92% Advancements Position GEO-CM04S1 as a Leading Vaccine Candidate Addressing Unmet Medical Needs, Especially Among Immunocompromised Patients ATLANTA, GA - January 13, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in immunotherapies and vaccines against infectious diseases and cancers, is pleased to announce substantial progress in the clinical development of its COVID-19 vaccine portfolio during 2024. These achievements underscore the potential of GEO-CM04S1 to address critical public health needs, particularly among immunocompromised populations. Project NextGen (PNG) Award In June 2024, GeoVax received a significant award through the Rapid Response Partnership Vehicle (RRPV), funded by the Biomedical Advanced Research and Development Authority (BARDA) as part of PNG. This award supports a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 compared to an approved COVID-19 vaccine. The study is set to commence in the second half of 2025, with Allucent, a global clinical research organization, selected to conduct and manage the trial. Chronic Lymphocytic Leukemia (CLL) Interim Study Results In November 2024, the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 clinical trial of GEO-CM04S1 as a booster vaccine for patients with CLL conducted an interim data review of the study. Following its review, the DSMB recommended that the study should continue enrollment of the experimental arm utilizing GEO-CM04S1, but that the mRNA control arm of the study should be halted as it failed to meet the predetermined primary immune endpoint. This suggests a potentially superior immune response in this vulnerable population. Further enrollment of the remaining patient participants is expected to be completed during 2025. Completion of Enrollment in Booster Vaccine Study for Healthy Adult Volunteers GeoVax has successfully completed enrollment in its Phase 2 clinical trial evaluating GEO-CM04S1 as a booster vaccine in healthy adults who previously received COVID-19 vaccines. This study aims to assess the vaccine's safety and immunogenicity at two different dose levels, with data readouts anticipated in the first half of 2025. Ongoing Stem Cell Transplant Study The Company continues to advance its Phase 2 clinical trial of GEO-CM04S1 as a primary vaccine for immunocompromised patients undergoing stem cell transplantation. This study addresses a critical need for effective vaccination strategies in populations that may not respond adequately to existing vaccines. Story continues Potential Benefits of GEO-CM04S1 Over Existing Authorized COVID-19 Vaccines GEO-CM04S1 offers several potential benefits compared to currently authorized COVID-19 vaccines: Public Health Impact : By providing robust protection for immunocompromised individuals, GEO-CM04S1 could significantly reduce COVID-19-related risks of morbidity and mortality among such high-risk patient populations. Durability : Preliminary data suggest that GEO-CM04S1 may offer longer-lasting immunity, potentially reducing the frequency of booster doses required. Breadth of Protection : The inclusion of both Spike (S) and Nucleocapsid (N) antigens in GEO-CM04S1 may confer broader immunity, making it more effective against a range of variants without the need for frequent reformulation. Primary Vaccine for Immunocompromised Patients : With approximately 40 million immunocompromised individuals in the U.S. and an estimated 400+ million worldwide, many of whom may not respond adequately to current vaccines, GEO-CM04S1 has the potential to become the preferred vaccine for this population. Safety. The safety profile of MVA as the platform for GEO-CM04S1 is well-established, with decades of data supporting its use as a smallpox vaccine, as well as its use as a platform with diverse vaccine candidates. This robust safety record is particularly important as the new HHS administration prioritizes transparency and rigorous oversight in vaccine safety evaluation. GEO-CM04S1 aligns with these priorities, offering a scientifically validated platform backed by comprehensive safety data. Market Potential and Partnering Opportunities GEO-CM04S1 offers an alternative approach to boosting existing COVID-19 vaccines, providing enhanced and more durable immunity. Its applicability for immunocompromised patients further broadens its public health and commercial value. GeoVax estimates the annual market potential for GEO-CM04S1 to be approximately $30 billion, reflecting the critical medical need to better address high-risk immunocompromised patients. The global need for a next-generation COVID-19 vaccine with the advantages offered by GEO-CM04S1 creates multiple partnering opportunities for GeoVax. Looking Ahead to 2025 The continued development of GEO-CM04S1 is a key component of GeoVax's catalyst-rich agenda for 2025. The Company anticipates multiple data readouts and regulatory milestones that will further define the vaccine's role in combating COVID-19. \"Our progress in 2024 has been remarkable, particularly in advancing GEO-CM04S1 as a next-generation COVID-19 vaccine,\" said David Dodd, Chairman & CEO of GeoVax. \"The MVA platform underlying our vaccine offers unique advantages, including the potential for broader and more durable protection, which is especially critical for immunocompromised individuals. We are committed to delivering solutions that address unmet medical needs and improve public health outcomes.\" Upcoming Presentations GeoVax's CEO, David Dodd, will present the Company's 2024 progress and future outlook at the following conferences: Biotech Showcase : January 14, 2025, at 10:30 AM PST Emerging Growth Conference : January 16, 2025, at 2:35 PM ET For more information on GeoVax's portfolio and developments, please visit www.geovax.com About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin(R) combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com . Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words \"believe,\" \"look forward to,\" \"may,\" \"estimate,\" \"continue,\" \"anticipate,\" \"intend,\" \"should,\" \"plan,\" \"could,\" \"target,\" \"potential,\" \"is likely,\" \"will,\" \"expect\" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: Investor Relations Contact: Media Contact: info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com 678-384-7220 212-698-8696 202-779-0929 View comments Terms and Privacy Policy Privacy Dashboard Recommended stories", "symbol": "GOVX", "date": "2025-01-13T14:00:00+00:00", "sentiment": {"score": 0.8743324708193541, "confidence": 0.892552375793457, "probabilities": {"positive": 0.892552375793457, "negative": 0.018219904974102974, "neutral": 0.08922769874334335}}, "embedding": [-0.07941348850727081, -0.02162572182714939, 0.09938765317201614, -0.16190971434116364, -0.089964359998703, -0.006491749547421932, -0.06679249554872513, 0.09003862738609314, -0.008571689948439598, 0.0607241652905941, -0.12446296960115433, 0.030888162553310394, 0.1796320378780365, 0.12949323654174805, -0.08866457641124725, 0.031113222241401672, 0.036787331104278564, -0.013944756239652634, -0.07410253584384918, 0.049111682921648026, 0.027374278753995895, -0.06374413520097733, 0.1079883724451065, 0.06701777875423431, -0.15724888443946838, -0.04338937997817993, -0.1228412613272667, -0.017478084191679955, -0.030655216425657272, 0.023671166971325874, 0.008644536137580872, -0.005746070295572281, -0.09308449178934097, -0.02919233962893486, -0.1275089532136917, -0.01694367080926895, -0.04836838319897652, 0.099868044257164, -0.041040465235710144, 0.025629287585616112, -0.03936471790075302, -0.027974482625722885, 0.002514032879844308, 0.013376085087656975, 0.10163180530071259, -0.14097249507904053, -0.0837605744600296, 0.031108379364013672, -0.011019377037882805, 0.1513684093952179, -0.1033158004283905, -0.18539689481258392, -0.015412586741149426, 0.07055209577083588, -0.0795721709728241, -0.0592387393116951, -0.1621382087469101, -0.010609865188598633, 0.08065859973430634, -0.0201906468719244, -0.08791977167129517, -0.1292504519224167, -0.050063036382198334, 0.10270600020885468, 0.06756563484668732, -0.0005820938386023045, 0.07411446422338486, 0.016819387674331665, -0.01633245125412941, -0.06930792331695557, 0.020841754972934723, 0.07639627158641815, -0.09652848541736603, 0.07757242023944855, -0.06787868589162827, 0.21699702739715576, 0.1974634826183319, 0.09581122547388077, 0.1927247792482376, -0.05813205614686012, 0.11370997130870819, 0.09935034066438675, 0.11663873493671417, -0.06273946911096573, -0.03947053104639053, 0.0578918494284153, 0.026292726397514343, 0.15792003273963928, 0.021758800372481346, 0.007775489240884781, 0.19879676401615143, 0.0031947847455739975, 0.05291879177093506, 0.18635207414627075, -0.041052933782339096, -0.02349960431456566, -0.001337917521595955, 0.006810567807406187, 0.1073564887046814, -0.031715042889118195, -0.0018940536538138986, -0.13659480214118958, 0.032276593148708344, -0.03313516825437546, 0.07391588389873505, -0.07094695419073105, 0.017257437109947205, -0.0312814861536026, -0.039445459842681885, -0.03029181808233261, -0.07698741555213928, 0.14780253171920776, -0.006728076376020908, 0.02551400661468506, -0.07841406762599945, 0.24843358993530273, -0.11971472203731537, -0.021402807906270027, 0.16781213879585266, -0.13848599791526794, 0.05756063386797905, -0.1454237997531891, 0.021533841267228127, -0.1348172426223755, 0.10453471541404724, 0.07327743619680405, 0.0851944237947464, 1.175570757955091e-32, 0.024078406393527985, 0.003102540969848633, 0.18082399666309357, 0.10847266018390656, -0.10470226407051086, 0.06744704395532608, 0.015400526113808155, 0.08516327291727066, -0.19541189074516296, -0.0886128842830658, -0.03670031577348709, 0.0872606635093689, 0.050078410655260086, 0.2506803274154663, -0.03827076405286789, 0.03406883031129837, -0.04146306961774826, -0.03436705470085144, -0.1435401290655136, 0.10901246964931488, 0.044713690876960754, -0.009915458038449287, 0.07506174594163895, 0.09821464121341705, 0.05303214490413666, 0.11091015487909317, -0.03066912665963173, 0.058129698038101196, -0.11647757887840271, 0.034831028431653976, -0.11140410602092743, -0.02581663616001606, 0.02149483561515808, -0.0537005253136158, -0.038720015436410904, -0.07627782970666885, -0.06632266193628311, -0.15027201175689697, 0.06900768727064133, 0.009263679385185242, 0.004219291731715202, 0.06414403021335602, -0.051443904638290405, -0.024627096951007843, 0.12036415934562683, -0.2271437793970108, -0.026092298328876495, -0.11065825819969177, -0.07060060650110245, 0.059820834547281265, 0.034006357192993164, 0.11068940162658691, -0.12612232565879822, -0.06373225897550583, -0.02772798016667366, 0.01237898413091898, -0.039211563766002655, 0.05945109575986862, 0.0841502696275711, 0.04797632247209549, 0.05974513292312622, 0.04653199017047882, 0.0009649989660829306, 0.09734387695789337, 0.05491149052977562, -0.06018431857228279, -0.012566999532282352, -0.05274192988872528, -0.07436498254537582, 0.14294102787971497, 0.06454025208950043, -0.10307870805263519, 0.06544390320777893, -0.02112649194896221, 0.1232142299413681, -0.1902875155210495, 0.13189701735973358, 0.029419953003525734, 0.03838053345680237, 0.12072253227233887, -0.05856054276227951, 0.0731387510895729, -0.06878484785556793, 0.13958896696567535, -0.0696258544921875, -0.11176558583974838, 0.0745406225323677, 0.0386262908577919, -0.06996872276067734, 0.013901351019740105, 0.06321476399898529, 7.688440382480621e-05, -0.07770144194364548, 0.1303429901599884, -0.039041899144649506, -1.2596299181720112e-32, -0.041569240391254425, -0.035330988466739655, 0.0010789316147565842, -0.02159840241074562, -0.07852045446634293, -0.009054861962795258, 0.22987905144691467, -0.08946023881435394, 0.1086774617433548, -0.11904507875442505, 0.08885741233825684, 0.05654458701610565, 0.061146434396505356, 0.13494135439395905, -0.030070612207055092, -0.016574211418628693, -0.0836988314986229, -0.10979804396629333, -0.26076000928878784, 0.07302028685808182, 0.12032030522823334, 0.11400948464870453, 0.003563609439879656, -0.02054688334465027, 0.009316233918070793, -0.02898470312356949, 0.17283830046653748, 0.08958422392606735, 0.02296287752687931, -0.05961605906486511, 0.029669057577848434, 0.07141363620758057, -0.11217980086803436, 0.044049233198165894, 0.005434031598269939, -0.125970721244812, 0.24935734272003174, -0.20639875531196594, 0.015074675902724266, -0.14082498848438263, 0.032612018287181854, 0.04261263087391853, -0.004491893574595451, -0.01643872633576393, 0.07207196950912476, 0.20173661410808563, 0.11463220417499542, 0.024529315531253815, 0.04387320578098297, 0.10337550938129425, -0.05618424341082573, 0.032180123031139374, -0.030271312221884727, 0.0770961195230484, -0.007480742409825325, -0.1773962378501892, -0.033975474536418915, -0.10782505571842194, -0.05536804348230362, -0.046384379267692566, 0.04262807220220566, 0.009048232808709145, 0.03650890290737152, -0.0667928159236908, 0.08127492666244507, 0.17588159441947937, 0.11530612409114838, 0.06795023381710052, 0.040813788771629333, -0.01165713556110859, -0.14124304056167603, -0.009970346465706825, -0.1439972221851349, -0.30781829357147217, -0.09298337996006012, 0.07012429088354111, -0.07801881432533264, -0.004503658972680569, -0.06996145099401474, -0.0909850001335144, 0.03447066992521286, -0.13052304089069366, 0.017292294651269913, -0.0051575396209955215, 0.19209682941436768, 0.08378604799509048, -0.013323158957064152, -0.01979919709265232, -0.016639111563563347, 0.040708139538764954, -0.1927880346775055, -0.08211902529001236, -0.11705102771520615, 0.053971096873283386, -0.08353320509195328, -1.006615164556024e-07, 0.11659886687994003, -0.006657128222286701, -0.054907284677028656, -0.042216114699840546, -0.05274524539709091, 0.050169687718153, -0.16888873279094696, -0.09297806769609451, 0.015297562815248966, 0.08890608698129654, 0.18262583017349243, 0.10543601959943771, -0.03529726341366768, -0.02997116558253765, 0.02548855170607567, -0.036535605788230896, -0.07566201686859131, -0.03920088708400726, -0.07315006852149963, -0.002637065015733242, -0.08217962086200714, -0.01528002880513668, -0.05674585700035095, -0.045851148664951324, 0.03136134147644043, -0.007921446114778519, 0.11778819561004639, 0.058712124824523926, 0.08994067460298538, -0.3035553991794586, -0.03850449621677399, -0.05873336270451546, -0.05398852378129959, -0.03959743306040764, -0.01298869401216507, -0.08101221919059753, 0.09417232125997543, 0.14581578969955444, 0.20366252958774567, 0.12554265558719635, 0.07558730989694595, 0.009565613232553005, -0.04068020358681679, -0.0018738526850938797, -0.1010727807879448, -0.050363749265670776, -0.11004262417554855, -0.0636611357331276, 0.03254604712128639, -0.12732428312301636, -0.17629802227020264, -0.14333172142505646, -0.14045265316963196, -0.02718658372759819, -0.0047746566124260426, 0.1564950793981552, -0.08617997169494629, -0.123688243329525, 0.04409020394086838, -0.04817334562540054, -0.00811295211315155, -0.17558065056800842, -0.05353129282593727, -0.06900440156459808], "changes": {"1wk": 4.716988134401508}}, {"text": "Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now Emerging Growth Wed, Jan 15, 2025, 3:00 PM 4 min read In This Article: IPWR +0.73% NZAUF 0.00% ELRRF +1.35% BVAXF +10.58% VANI -1.68% Emerging Growth MIAMI, Jan. 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 78 th Emerging Growth Conference on January 15 & 16, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here . Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 - Today January 15, 2025 9:00 Virtual Lobby opens. Register for the Conference . If you already registered, go back to the registration link and click \u201cAlready registered\u201d and enter your email. 9:35 Introduction 9:40 \u2013 10:10 Brazil Potash (NYSE American: GRO) Keynote speaker: Matt Simpson, CEO & Mayo Schmidt, Executive Chairman 10:15 \u2013 10:45 XBP Europe Holdings, Inc. (NASDAQ: XBP) Keynote speaker: Andrej Jonovic, CEO & Director 11:25 - 11:55 MarketWise , Inc. (NASDAQ: MKTW) Keynote speaker: Erik Mickels, CFO 1:10 \u2013 1:40 Alt Equity \u2013 A private company Keynote speaker: Daniel Wait, President / Founder 1:45 \u2013 2:15 Regen BioPharma Inc. (OTC Pink: RGBP) Keynote speakers: David Koos, President / CEO, and Harry M. Lander, Ph.D. Senior Scientific Consultant 2:20 \u2013 2:50 Cannabis Bioscience International Holdings Inc. (OTC Pink: CBIH) Keynote speakers: Dante Picaso, President / CEO 2:55 \u2013 3:05 The Birch Co. (OTC Pink: ATWT) Keynote speaker: Angus Martin, President & CEO 3:10 \u2013 3:20 U Power Limited (NASDAQ: UCAR) Keynote speaker: Paul Li, UCAR European Representative 3:25 - 3:35 Brenmiller Energy, Ltd. (NASDAQ: BNRG) Keynote speaker: Nir Brenmiller, COO 3:40 \u2013 3:50 Monumental Energy Corp. (OTCQB: MNMRF) (TSXV: MNRG) Keynote speaker: Maximilian Sali, VP Corporate Development, Founder & Director 3:55 \u2013 4:05 Sky Harbour Group Corporation (NYSE American: SKYH) Keynote speakers: Tal Keinan, Founder and CEO 4:10 \u2013 4:20 Cyios Corp. (OTC Pink: CYIO) Keynote speaker: John O\u2019Shea, Chairman Day 2 - Tomorrow January 16, 2025 12:00 Virtual Lobby opens. Register for the Conference . If you already registered, go back to the registration link and click \u201cAlready registered\u201d and enter your email. 12:30 Introduction 12:35 \u2013 1:05 Tytonyx, a private company Keynote speakers: Jim Snow, Director 1:10 - 1:40 Bioxytran, Inc. (OTCQB: BIXT) Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development 1:45 - 2:15 RUA Gold, Inc. (OTCQB: NZAUF) (CSE: RUA) Keynote speaker: Robert Eckford, CEO Story Continues 2:20 \u2013 2:30 Ideal Power, Inc. (NASDAQ: IPWR) Keynote speakers: Dan Brdar: President and CEO, & Tim Burns: CFO 2:35 \u2013 3:05 GeoVax Labs, Inc. (NASDAQ: GOVX) Keynote speakers: David Dodd, Chairman, President / CEO 3:10 - 3:20 Vivani Medical, Inc. (NASDAQ: VANI) Keynote speaker: Adam Mendelsohn PHD, CEO 3:25 - 3:35 BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) Keynote speaker:\u00a0James Passin, CEO 3:40 \u2013 3:50 Viomi Technology Co., Ltd. (NASDAQ: VIOT) Keynote speakers: Claire Ji \u2013 IR & Finance, and Sam Yang, Head of Capital and Strategy 3:55 \u2013 4:05 Eloro Resources, Ltd. (OTCQX: ELRRF) (TSX: ELO) Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration 4:10 \u2013 4:20 Realbotix Corp. (OTCQB: XBOTF) (TSXV: XBOT) Keynote speaker: Andrew Kiguel Co-Founder, CEO Visit the following link to register. You will then receive an email containing the link and time to sign into the conference. Register for the Conference here . Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com Replays: Subscribe to our YouTube Channel About\u00a0EmergingGrowth.com Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community. About the Emerging Growth Conference The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner. All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.\u00a0 Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.\u00a0 In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com. If you believe or know of a company that might fit our audience, contact us here . Thank you for your interest in our conference, and we look forward to your participation in future conferences. Contact: Emerging Growth Phone: 1-305-330-1985 Email: Conference@EmergingGrowth.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-15T12:00:00+00:00", "sentiment": {"score": 0.03844411764293909, "confidence": 0.053061362355947495, "probabilities": {"positive": 0.053061362355947495, "negative": 0.014617244713008404, "neutral": 0.9323213696479797}}, "embedding": [0.01837669499218464, -0.13674181699752808, 0.01146206259727478, 0.04903906211256981, 0.10855382680892944, 0.0692763403058052, -0.05009327828884125, 0.039778560400009155, 0.07027231901884079, 0.02156037464737892, -0.0450175479054451, 0.018360398709774017, -0.1170501559972763, 0.0008763698861002922, -0.07977922260761261, 0.00286449259147048, -0.0005458183586597443, -0.06499221920967102, -0.04997961223125458, -0.049010973423719406, -0.010522035881876945, -0.06625885516405106, -0.003352746367454529, 0.05692578852176666, -0.012204645201563835, 0.04735974967479706, -0.11440452188253403, 0.009669807739555836, -0.06875158846378326, -0.10067214071750641, 0.024286095052957535, 0.1442534178495407, 0.11289355158805847, -0.019304320216178894, 0.040071435272693634, -0.014474552124738693, -0.016826804727315903, 0.028209485113620758, 0.013008490204811096, -0.02869158610701561, 0.052555955946445465, -0.07609035074710846, -0.07453986257314682, -0.011255946010351181, 0.03932567313313484, -0.1579928696155548, -0.027434099465608597, 0.04356468841433525, -0.033272936940193176, -0.011658765375614166, -0.03541279584169388, -0.06673969328403473, 0.05588959902524948, -0.012074083089828491, -0.04092532768845558, 0.04831146448850632, -0.09626742452383041, -0.07151246070861816, 0.07558023184537888, 0.009035235270857811, -0.0037416615523397923, -0.07328838109970093, -0.010039485059678555, 0.054132819175720215, 0.0462823323905468, 0.011840097606182098, -0.031023014336824417, 0.0803266316652298, -0.10763309895992279, -0.04530436918139458, -0.01518935989588499, -0.04277116805315018, -0.0052798353135585785, 0.10420043021440506, 0.01411797571927309, 0.1283542811870575, 0.027018744498491287, 0.10540542006492615, 0.12132949382066727, -0.00862217415124178, 0.06527066230773926, 0.10513108968734741, -0.024549107998609543, -0.055098533630371094, -0.036918774247169495, -0.00419224239885807, 0.0604490265250206, 0.010800138115882874, 0.008939473889768124, -0.027798835188150406, 0.002680243458598852, 0.07497023791074753, -0.04436448961496353, 0.04890957102179527, -0.025467639788985252, -0.003268658183515072, -0.05934852361679077, -0.1184130311012268, 0.03289002180099487, 0.031193990260362625, 0.046186208724975586, 0.09149223566055298, -0.027561135590076447, -0.07175067067146301, -0.09917524456977844, -0.08045508712530136, -0.04329853877425194, 0.019610943272709846, 0.10325347632169724, 0.09706158190965652, -0.04366965591907501, 0.07331380248069763, -0.02812526747584343, -0.012603109702467918, -0.05212096869945526, 0.043655190616846085, -0.06207488477230072, 0.003412727266550064, 0.12827596068382263, -0.03441765531897545, 0.0401739627122879, 0.059713855385780334, -0.06293405592441559, -0.03307391330599785, -0.0745062604546547, 0.0006407832261174917, -0.08050677180290222, 1.6752873654850614e-32, -0.031181054189801216, 0.050706006586551666, 0.037295863032341, 0.07249827682971954, 0.005669539328664541, 0.005090757273137569, -0.02634289115667343, -0.07799262553453445, -0.18145911395549774, -0.052941203117370605, -0.1482342630624771, 0.1039091944694519, -0.011790595948696136, 0.005147856660187244, -0.015302691608667374, -0.0781937837600708, -0.043494291603565216, 0.06326557695865631, 0.0034523666836321354, -0.11110357940196991, -0.02798670530319214, 0.0720883458852768, -0.0844002515077591, 0.08903124183416367, 0.031362857669591904, 0.07068008929491043, -0.00946011207997799, -0.11727830767631531, 0.014356476254761219, 0.058706559240818024, -0.03227183595299721, 0.026166826486587524, -0.10287448763847351, -0.07604976743459702, -0.0491267666220665, -0.015099532902240753, -0.05758310854434967, -0.11857332289218903, 0.03568688780069351, 0.02388891577720642, -0.04879571497440338, 0.07233705371618271, -0.050185590982437134, -0.055253587663173676, -0.032322607934474945, -0.031014397740364075, 0.04256924241781235, 0.028043292462825775, 0.14276164770126343, 0.00305839441716671, -0.09801612049341202, -0.028731442987918854, 0.005068778060376644, -0.0454903282225132, 0.06866980344057083, 0.014561420306563377, -0.11121895909309387, -0.039616234600543976, 0.08512800931930542, 0.036906421184539795, -0.029714055359363556, 0.11397094279527664, -0.13259673118591309, 0.028515495359897614, -0.13652245700359344, 0.06522951275110245, 0.013116239570081234, 0.054914578795433044, 0.044493578374385834, 0.08649951219558716, 0.07211558520793915, -0.04983268305659294, 0.08555752038955688, -0.01292917225509882, 0.07841046154499054, -0.05793418735265732, 0.027507523074746132, 0.09455636143684387, -0.021047864109277725, 0.09049451351165771, -0.012138454243540764, 0.02689782902598381, -0.015569321811199188, 0.026974406093358994, -0.07058994472026825, -0.054313644766807556, 0.04219646006822586, 0.10527531057596207, -0.05439942330121994, 0.013285284861922264, -0.0031213019974529743, -0.0545269176363945, 0.08534831553697586, 0.11331462115049362, -0.07084444910287857, -1.6678423720141284e-32, 0.10559196025133133, -0.08632881194353104, 0.02101348154246807, -0.04812750220298767, 0.04756534844636917, 0.0038713421672582626, 0.016477512195706367, -0.024787327274680138, -0.0255885012447834, -0.18749374151229858, 0.01398398820310831, 0.10162577778100967, -0.0032367021776735783, 0.02611025795340538, -0.021730754524469376, -0.049598827958106995, 0.05732126906514168, -0.023257099092006683, -0.05424681305885315, 0.01316821202635765, 0.03444812074303627, 0.08129777014255524, -0.09744278341531754, 0.08928008377552032, 0.008714653551578522, 0.009083296172320843, 0.06025344878435135, 0.07631256431341171, 0.02159002609550953, -0.02186754159629345, -0.08568286150693893, 0.05763597413897514, -0.185985267162323, 0.10813088715076447, 0.019280798733234406, 0.008635295554995537, -0.04164642095565796, -0.1044984832406044, -0.028104539960622787, -0.0016397549770772457, 0.05569048970937729, 0.0472102165222168, -0.015262980945408344, 0.0007120762020349503, 0.03985688090324402, 0.01155838742852211, 0.028608158230781555, -0.02247774228453636, 0.04566848278045654, 0.0714481920003891, -0.06357027590274811, 0.07811838388442993, -0.06829818338155746, 0.005926762241870165, -0.06392133235931396, 0.04317699372768402, -0.017751134932041168, 0.009890072979032993, -0.10081557929515839, 0.022178485989570618, -0.03158284351229668, 0.10197265446186066, 0.02089301496744156, -0.032108377665281296, 0.037303633987903595, 0.01753062754869461, 0.017188861966133118, 0.041214048862457275, -0.04646456241607666, -0.05802302062511444, 0.05808161944150925, -0.054032519459724426, -0.059032686054706573, -0.08586550503969193, -0.046813782304525375, 0.05851394683122635, -0.013503310270607471, 0.014936600811779499, -0.07676997035741806, 0.011023408733308315, -0.01790257915854454, 0.04711393266916275, -0.019723044708371162, 0.035408616065979004, 0.06652295589447021, 0.08628958463668823, -0.037971220910549164, -0.045096755027770996, -0.047753799706697464, 0.11445395648479462, -0.0239644106477499, -0.1644667387008667, -0.08871936053037643, 0.06926267594099045, 0.07135988771915436, -1.0079013179620233e-07, 0.012560619972646236, 0.03323306888341904, 0.05218277871608734, -0.008408283814787865, 0.08726954460144043, -0.035162921994924545, 0.002212848514318466, 0.002078173216432333, 0.04667893052101135, 0.049860529601573944, 0.0892312228679657, 0.06583185493946075, -0.059840843081474304, 0.06996897608041763, -0.005914847366511822, 0.06719046086072922, -0.12086929380893707, 0.03567725419998169, -0.05487057566642761, -0.08435514569282532, -0.039420027285814285, 0.055266231298446655, 0.08411788940429688, -0.021508239209651947, -0.013599258847534657, -0.0988193154335022, -0.043639592826366425, -0.0065568289719522, 0.017084263265132904, -0.0626981109380722, 0.03600439429283142, 0.03861994296312332, -0.04182923585176468, -0.008153499104082584, 0.08747655153274536, 0.04054473340511322, -0.05612676590681076, 0.010221455246210098, 0.03170158341526985, 0.0529402457177639, -0.03806362673640251, -0.03732319921255112, 0.026231195777654648, -0.03878585249185562, -0.05042571201920509, -0.030108951032161713, -0.10423870384693146, 0.0479457825422287, 0.03585009649395943, -0.11736428737640381, -0.023225881159305573, -0.03852366656064987, 0.0005800323560833931, -0.008783990517258644, 0.024364909157156944, 0.1038288101553917, -0.05007537454366684, -0.04567769169807434, 0.0053451452404260635, -0.03037225641310215, 0.05786028504371643, -0.151039719581604, 0.013860313221812248, 0.11509914696216583], "changes": {"1wk": -1.3333320617675781}}, {"text": "Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now Emerging Growth Tue, Jan 14, 2025, 3:00 PM 4 min read In this article: XBP +0.97% XBPEW -0.50% SKYH -1.40% SKYH-WT -2.55% BNRG 0.00% Emerging Growth MIAMI, Jan. 14, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 78 th Emerging Growth Conference on January 15 & 16, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here . Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter Day 1 January 15, 2025 9:00 Virtual Lobby opens. Register for the Conference . \u00a0If you already registered, go back to the registration link and click \u201cAlready registered\u201d and enter your email. 9:35 Introduction 9:40 \u2013 10:10 Brazil Potash (NYSE American: GRO) Keynote speaker: Matt Simpson, CEO & Mayo Schmidt, Executive Chairman 10:15 \u2013 10:45 XBP Europe Holdings, Inc. (NASDAQ: XBP) Keynote speaker: Andrej Jonovic, CEO & Director 11:25 - 11:55 MarketWise , Inc. (NASDAQ: MKTW) Keynote speaker: Erik Mickels, CFO 1:10 \u2013 1:40 Alt Equity \u2013 A private company Keynote speaker: Daniel Wait, President / Founder 1:45 \u2013 2:15 Regen BioPharma Inc. (OTC Pink: RGBP) Keynote speakers: David Koos, President / CEO, and Harry M. Lander, Ph.D. Senior Scientific Consultant 2:20 \u2013 2:50 Cannabis Bioscience International Holdings Inc. (OTC Pink: CBIH) Keynote speakers: Dante Picaso, President / CEO 2:55 \u2013 3:05 The Birch Co. (OTC Pink: ATWT) Keynote speaker: Angus Martin, President & CEO 3:10 \u2013 3:20 U Power Limited (NASDAQ: UCAR) Keynote speaker: Paul Li, UCAR European Representative 3:25 - 3:35 Brenmiller Energy, Ltd. (NASDAQ: BNRG) Keynote speaker: Nir Brenmiller, COO 3:40 \u2013 3:50 Monumental Energy Corp. (OTCQB: MNMRF) (TSXV: MNRG) Keynote speaker: Maximilian Sali, VP Corporate Development, Founder & Director 3:55 \u2013 4:05 Sky Harbour Group Corporation (NYSE American: SKYH) Keynote speakers: Tal Keinan, Founder and CEO 4:10 \u2013 4:20 Cyios Corp. (OTC Pink: CYIO) Keynote speaker: John O\u2019Shea, Chairman Day 2 January 16, 2025 12:00 Virtual Lobby opens. Register for the Conference. If you already registered, go back to the registration link and click \u201cAlready registered\u201d and enter your email. 12:30 Introduction 12:35 \u2013 1:05 Tytonyx, a private company Keynote speakers: Jim Snow, Director 1:10 - 1:40 Bioxytran, Inc. (OTCQB: BIXT) Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development 1:45 - 2:15 RUA Gold, Inc. (OTCQB: NZAUF) (CSE: RUA) Keynote speaker: Robert Eckford, CEO Story continues 2:20 \u2013 2:30 Ideal Power, Inc. (NASDAQ: IPWR) Keynote speakers: Dan Brdar: President and CEO, & Tim Burns: CFO 2:35 \u2013 3:05 GeoVax Labs, Inc. (NASDAQ: GOVX) Keynote speakers: David Dodd, Chairman, President / CEO 3:10 - 3:20 Vivani Medical, Inc. (NASDAQ: VANI) Keynote speaker: Adam Mendelsohn PHD, CEO 3:25 - 3:35 BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) Keynote speaker:\u00a0James Passin, CEO 3:40 \u2013 3:50 Viomi Technology Co., Ltd. (NASDAQ: VIOT) Keynote speakers: Claire Ji \u2013 IR & Finance, and Sam Yang, Head of Capital and Strategy 3:55 \u2013 4:05 Eloro Resources, Ltd. (OTCQX: ELRRF) (TSX: ELO) Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration 4:10 \u2013 4:20 Realbotix Corp. (OTCQB: XBOTF) (TSXV: XBOT) Keynote speaker: Andrew Kiguel Co-Founder, CEO Visit the following link to register. You will then receive an email containing the link and time to sign into the conference. Register for the Conference here . Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com Replays: Subscribe to our YouTube Channel About\u00a0EmergingGrowth.com Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community. About the Emerging Growth Conference The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner. All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.\u00a0 Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.\u00a0 In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com. If you believe or know of a company that might fit our audience, contact us here. Thank you for your interest in our conference, and we look forward to your participation in future conferences. Contact: Emerging Growth Phone: 1-305-330-1985 Email: Conference@EmergingGrowth.com View comments Terms and Privacy Policy Privacy Dashboard Recommended stories", "symbol": "GOVX", "date": "2025-01-14T12:00:00+00:00", "sentiment": {"score": 0.03277732711285353, "confidence": 0.04824051260948181, "probabilities": {"positive": 0.04824051260948181, "negative": 0.015463185496628284, "neutral": 0.936296284198761}}, "embedding": [0.0201659444719553, -0.14736711978912354, 0.013392030261456966, 0.04303682968020439, 0.11647665500640869, 0.06918752193450928, -0.04278361797332764, 0.04835667461156845, 0.07117430120706558, 0.014325279742479324, -0.044118572026491165, 0.02048054337501526, -0.12514179944992065, -0.01454155519604683, -0.09039469063282013, 0.010388818569481373, 0.013471291400492191, -0.0832252949476242, -0.05856587737798691, -0.05512774735689163, -0.007540828548371792, -0.07158400863409042, -0.01087548304349184, 0.06937830150127411, -0.008020234294235706, 0.04339443892240524, -0.11105229705572128, -0.0056967101991176605, -0.06780459731817245, -0.09193761646747589, 0.03814423456788063, 0.14337652921676636, 0.11534056067466736, -0.016354724764823914, 0.04163747280836105, -0.007530373055487871, -0.0015640025958418846, 0.015759875997900963, 0.008593072183430195, -0.03513818234205246, 0.056453462690114975, -0.08332718163728714, -0.07355791330337524, -0.004593200515955687, 0.04931020736694336, -0.16457970440387726, -0.02832145243883133, 0.04901549592614174, -0.04522637277841568, -0.003783002495765686, -0.03883920609951019, -0.07357683777809143, 0.04607728123664856, -0.00351081695407629, -0.04184059053659439, 0.05727101489901543, -0.09584902226924896, -0.06755401194095612, 0.0637504905462265, 0.002190718427300453, -0.004545832052826881, -0.06913328915834427, -0.005968022625893354, 0.050578709691762924, 0.034382738173007965, 0.013714715838432312, -0.023154083639383316, 0.08791354298591614, -0.10183193534612656, -0.04423496872186661, -0.013801924884319305, -0.04645416885614395, -0.005194247700273991, 0.10730940103530884, 0.008470586501061916, 0.11545318365097046, 0.03905598446726799, 0.1071610227227211, 0.13466164469718933, -0.016095876693725586, 0.061369895935058594, 0.11924870312213898, -0.0371326208114624, -0.05438699573278427, -0.04536006599664688, -0.009436553344130516, 0.04939010739326477, 0.029456641525030136, 0.008188831619918346, -0.010476384311914444, -0.005988866090774536, 0.0793960690498352, -0.05694857984781265, 0.04527119919657707, -0.03206547349691391, -0.0016439417377114296, -0.06002207100391388, -0.1276577115058899, 0.0414990559220314, 0.01980399899184704, 0.046522580087184906, 0.09005752205848694, -0.015054087154567242, -0.06908600777387619, -0.11061432957649231, -0.09238547086715698, -0.042047169059515, 0.014900008216500282, 0.09865061938762665, 0.0898175910115242, -0.049536436796188354, 0.0644070953130722, -0.024794097989797592, -0.004305223468691111, -0.04639311134815216, 0.05579077824950218, -0.06697079539299011, -0.010071109049022198, 0.12400203943252563, -0.039424799382686615, 0.046122096478939056, 0.06630556285381317, -0.048071086406707764, -0.027325410395860672, -0.08068886399269104, -0.006978299468755722, -0.08633974939584732, 1.612148772103313e-32, -0.020840540528297424, 0.04436298459768295, 0.03705679625272751, 0.07774164527654648, 0.007891656830906868, 0.00991457886993885, -0.02208574488759041, -0.06963424384593964, -0.18804779648780823, -0.04395740106701851, -0.1498706191778183, 0.08582380414009094, -0.010798584669828415, -0.014834408648312092, -0.003873727284371853, -0.07119759917259216, -0.0533856600522995, 0.08254243433475494, -0.0177646242082119, -0.11378701776266098, -0.038438864052295685, 0.06749677658081055, -0.09347016364336014, 0.0909837931394577, 0.031225016340613365, 0.08734601736068726, -0.017829125747084618, -0.11433765292167664, 0.01737729273736477, 0.05837636440992355, -0.04245319217443466, 0.028670858591794968, -0.10351258516311646, -0.06586722284555435, -0.06126530468463898, -0.00013735517859458923, -0.05720800906419754, -0.11723122000694275, 0.046114232391119, 0.039214346557855606, -0.04372274503111839, 0.07334998995065689, -0.042555928230285645, -0.06210585683584213, -0.022255055606365204, -0.02510996162891388, 0.039704855531454086, 0.016372429206967354, 0.13906630873680115, -0.007876729592680931, -0.08849052339792252, -0.036775022745132446, 0.008761623874306679, -0.03841838240623474, 0.08440125733613968, 0.024996064603328705, -0.12477156519889832, -0.029484426602721214, 0.07618092000484467, 0.030623391270637512, -0.022691164165735245, 0.10362325608730316, -0.13508348166942596, 0.03530578315258026, -0.13884267210960388, 0.06800719350576401, 0.01658478006720543, 0.062431879341602325, 0.045756787061691284, 0.09191404283046722, 0.0688299834728241, -0.06398728489875793, 0.08896748721599579, -0.005756499245762825, 0.09111878275871277, -0.061943694949150085, 0.03039432130753994, 0.10164399445056915, -0.025118732824921608, 0.10576930642127991, 0.0007812019903212786, 0.025352954864501953, -0.012672299519181252, 0.012761810794472694, -0.06284330040216446, -0.04199972376227379, 0.052862539887428284, 0.11341327428817749, -0.05532011389732361, 0.014505606144666672, -0.010891023091971874, -0.05453288555145264, 0.085573710501194, 0.11858795583248138, -0.07663179188966751, -1.6035873528726867e-32, 0.10080713033676147, -0.09220847487449646, 0.020762937143445015, -0.03894931823015213, 0.045472152531147, 0.011784161441028118, 0.0062403068877756596, -0.023826327174901962, -0.027013909071683884, -0.19558817148208618, 0.009827900677919388, 0.09595576673746109, -0.01426836010068655, 0.02410302497446537, -0.017110612243413925, -0.05034923553466797, 0.05762600153684616, -0.026566069573163986, -0.06600114703178406, 0.010202856734395027, 0.03360755369067192, 0.08414694666862488, -0.09959208965301514, 0.07729034125804901, 0.005114273633807898, 0.004656784702092409, 0.056047916412353516, 0.07453102618455887, 0.04136282950639725, -0.014749495312571526, -0.09165044128894806, 0.06760268658399582, -0.18292346596717834, 0.11084717512130737, 0.02512511983513832, 0.00479913130402565, -0.048911236226558685, -0.11370217055082321, -0.021845245733857155, 0.009836262091994286, 0.057903021574020386, 0.0503540113568306, -0.007474425248801708, 0.0041694119572639465, 0.0357983224093914, 0.02441939152777195, 0.021273553371429443, -0.025896530598402023, 0.039251551032066345, 0.07707015424966812, -0.059049900621175766, 0.0653771311044693, -0.07904508709907532, 0.013694114983081818, -0.07737360894680023, 0.057652030140161514, -0.02681688964366913, 0.017842426896095276, -0.10371306538581848, 0.01604437083005905, -0.031347304582595825, 0.10905487090349197, 0.025338061153888702, -0.03963179513812065, 0.033357977867126465, 0.01913430728018284, 0.021518120542168617, 0.052571531385183334, -0.05131141096353531, -0.053451161831617355, 0.06072463095188141, -0.060462191700935364, -0.06406532973051071, -0.08297442644834518, -0.03914492204785347, 0.06372196227312088, -0.012095984071493149, 0.02698354609310627, -0.07013776153326035, 0.006789294071495533, -0.025179745629429817, 0.061015672981739044, -0.00802917405962944, 0.037260282784700394, 0.06400835514068604, 0.08363586664199829, -0.04063080996274948, -0.02780028060078621, -0.045136772096157074, 0.12018589675426483, -0.03594045341014862, -0.1629660278558731, -0.0869639441370964, 0.07273539900779724, 0.07908947020769119, -1.0074941769744328e-07, 0.0022424166090786457, 0.04038195312023163, 0.05584157258272171, -0.0018003899604082108, 0.07811730355024338, -0.023239392787218094, -0.0020258240401744843, 0.007785012945532799, 0.06107815355062485, 0.03940042480826378, 0.07370548695325851, 0.05494680628180504, -0.0637221410870552, 0.07554861903190613, -0.011811465956270695, 0.05187932401895523, -0.12947404384613037, 0.030828215181827545, -0.05633644014596939, -0.09151773899793625, -0.04628324136137962, 0.059552982449531555, 0.09741721302270889, -0.025600768625736237, -0.022329362109303474, -0.10072363168001175, -0.052155233919620514, -0.00014191679656505585, 0.01752423495054245, -0.07050907611846924, 0.03599151223897934, 0.04514924809336662, -0.038116808980703354, 0.0044263312593102455, 0.08834300935268402, 0.046632058918476105, -0.06913873553276062, 0.012275162152945995, 0.039311401546001434, 0.06026330962777138, -0.03381019085645676, -0.04309334605932236, 0.028472725301980972, -0.0401771143078804, -0.053158581256866455, -0.03451426327228546, -0.09670000523328781, 0.04225480929017067, 0.02861744910478592, -0.11645020544528961, -0.025356000289320946, -0.03651703521609306, 0.003090091049671173, -0.022576063871383667, 0.03211536258459091, 0.11576563119888306, -0.0364963635802269, -0.046766892075538635, 0.002740897238254547, -0.03432773798704147, 0.0476570762693882, -0.1536516547203064, 0.005301766097545624, 0.12356756627559662], "changes": {"1wk": 5.213276729068684}}, {"text": "GeoVax to Review 2024 Progress at Biotech Showcase During J.P. Morgan Healthcare Week 2025 NewMediaWire Mon, Jan 6, 2025, 5:00 PM 2 min read In This Article: GOVX -7.33% GOVXW -22.92% ATLANTA, GA - January 6, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, Chief Executive Officer, will review 2024 progress in a presentation at the Biotech Showcase coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2025. Presentation Details: Presenter: David Dodd, Chairman & CEO Date/Time: January 14, 2025, 10:30 am PST Location: Hilton Union Square, 333 O'Farrell Street, Yosemite A (Ballroom Level), San Francisco, CA Registration: Biotech Showcase A live webcast of the presentation will be available here . A replay will be available approximately 2 hours after the presentation and accessible for three months. Additionally, senior management of GeoVax will be available for one-on-one meetings during the week with potential partners, collaborators, and investors. One-on-one appointments may be requested as follows: Through the Biotech Showcase partnering platform here . Through the Biotechnology Innovation Organization (BIO) partnering platform here . Direct outreach to the Company at info@geovax.com or to Precision AQ at maxmilian.gadicke@precisionaq.com About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin(R) combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com . Story Continues Company Contact: Investor Relations Contact: Media Contact: info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com 678-384-7220 212-698-8696 202-779-0929 View the original release on www.newmediawire.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-06T14:00:00+00:00", "sentiment": {"score": 0.09720373805612326, "confidence": 0.10670430213212967, "probabilities": {"positive": 0.10670430213212967, "negative": 0.009500564076006413, "neutral": 0.8837951421737671}}, "embedding": [-0.07263635098934174, -0.0969637781381607, 0.10937429964542389, -0.12596386671066284, -0.06587973982095718, -0.06274670362472534, -0.015289133414626122, 0.03402351960539818, -0.021876700222492218, 0.035574935376644135, -0.18108423054218292, 0.09206908941268921, 0.13378062844276428, 0.10297583043575287, -0.10678377002477646, -0.010363136418163776, 0.044103145599365234, -0.019164323806762695, -0.022614527493715286, 0.058687321841716766, 0.029603686183691025, 0.011659786105155945, 0.07295291125774384, -0.004662602208554745, -0.11803409457206726, 0.016801880672574043, -0.07946154475212097, -0.032955601811409, -0.13426807522773743, -0.03646672144532204, -0.01798579841852188, 0.044719502329826355, -0.06267207860946655, -0.09688208997249603, -0.08142979443073273, 0.031118005514144897, -0.017508648335933685, 0.05884317308664322, -0.028254525735974312, 0.0006307484582066536, -0.017158858478069305, -0.06874323636293411, -0.03112371638417244, 0.09478595107793808, 0.11208584904670715, -0.1641986072063446, -0.060258977115154266, -0.0763053148984909, 0.07202360033988953, 0.1458406299352646, -0.1473585069179535, -0.24699923396110535, 0.026642633602023125, 0.07520770281553268, -0.06269418448209763, -0.08811761438846588, -0.16161224246025085, -0.04849671572446823, 0.08308904618024826, -0.07687005400657654, 0.017461169511079788, -0.13220752775669098, -0.03540181368589401, 0.11529716849327087, 0.10217500478029251, 0.013211706653237343, 0.10319104045629501, 0.061280980706214905, -0.04392324015498161, -0.13416889309883118, 0.02571878954768181, 0.06986188143491745, -0.03597661107778549, 0.08100849390029907, -0.060687072575092316, 0.18813258409500122, 0.1742723286151886, 0.0695706456899643, 0.2531452178955078, -0.034893058240413666, 0.09961748123168945, 0.047546662390232086, 0.11870087683200836, 0.05299517139792442, -0.10184275358915329, 0.07429744303226471, 0.04774142801761627, 0.11714599281549454, 0.0567479208111763, -0.009406153112649918, 0.06684431433677673, 0.04696683958172798, 0.026930443942546844, 0.07674606889486313, -0.05793573707342148, -0.03223824501037598, -0.055419206619262695, -0.002826401963829994, 0.10258402675390244, 0.0012013902887701988, 0.009888764470815659, -0.06978920847177505, -0.04415065050125122, -0.04124092310667038, 0.01361999474465847, -0.07434157282114029, -0.06893771886825562, 0.04789213091135025, 0.04273679479956627, 0.01997457630932331, -0.10860708355903625, 0.20060080289840698, 0.001248086802661419, -0.018401846289634705, -0.09947733581066132, 0.3156450688838959, -0.03993653506040573, -0.005340727977454662, 0.11375757306814194, -0.14958325028419495, 0.06462018191814423, -0.10106618702411652, -0.031908974051475525, -0.12270019948482513, 0.08961693942546844, 0.049135733395814896, -0.02045515365898609, 9.975079022500878e-33, 0.002679472789168358, 0.02139560878276825, 0.2238031029701233, 0.0955001562833786, 0.08127835392951965, 0.04467244818806648, -0.009100651368498802, 0.0052111102268099785, -0.22045795619487762, -0.09456031024456024, -0.10805408656597137, 0.03445609286427498, 0.03151268884539604, 0.18523216247558594, -0.09825834631919861, -0.040613044053316116, -0.03830154240131378, -0.023664232343435287, -0.1068144217133522, 0.06224954128265381, 0.0201326385140419, 0.047099944204092026, 0.0535409078001976, 0.12874482572078705, 0.012511949986219406, 0.08364831656217575, -0.051589880138635635, 0.0846114307641983, 0.009923543781042099, 0.05042259767651558, -0.1763165295124054, -0.018903139978647232, -0.007739906199276447, -0.03237678483128548, 0.0004653399810194969, -0.09270304441452026, -0.03380341827869415, -0.19267699122428894, 0.05244871973991394, 0.012136388570070267, -0.030633628368377686, 0.07838194072246552, -0.07047590613365173, -0.06764230132102966, 0.12093453854322433, -0.12136492878198624, -0.009109933860599995, -0.05287715047597885, 0.03188730776309967, 0.09856729209423065, -0.06143172085285187, 0.15408368408679962, -0.08890299499034882, -0.04792780801653862, 0.042360518127679825, -0.010012544691562653, -0.04034791141748428, 0.030330665409564972, 0.07530809938907623, 0.1240474283695221, 0.09297323226928711, 0.16153934597969055, -0.06295295059680939, 0.054432738572359085, -0.06932199746370316, 0.016436783596873283, 0.0337228924036026, 0.00914673786610365, -0.04767778515815735, 0.1937406361103058, -0.0011603441089391708, 0.014765234664082527, 0.05113176628947258, -0.03617943823337555, 0.09237979352474213, -0.13766363263130188, 0.04247443377971649, 0.007627476938068867, 0.022029295563697815, 0.05013726279139519, -0.047277264297008514, 0.041717786341905594, -0.044198352843523026, 0.16690394282341003, -0.07755385339260101, -0.07289993762969971, 0.037633489817380905, 0.06236012279987335, -0.09507545828819275, -0.011550583876669407, 0.04629739001393318, -0.00147155299782753, -0.04107559472322464, 0.09200141578912735, -0.04779290407896042, -1.2084408126135469e-32, -0.07999041676521301, -0.05922270566225052, -0.04098178818821907, -0.01802300103008747, -0.10430610179901123, 0.008463190868496895, 0.12032819539308548, -0.06013738736510277, 0.11207275092601776, -0.10211023688316345, 0.07576312869787216, 0.1669432371854782, 0.05008804053068161, 0.10752056539058685, -0.082807756960392, 0.02232939749956131, -0.042554821819067, -0.1500934660434723, -0.2521607279777527, -0.008021256886422634, 0.09603536128997803, 0.1789417415857315, -0.05264796316623688, -0.021816277876496315, -0.019769655540585518, 0.020175857469439507, 0.17915546894073486, 0.16325479745864868, 0.06358873099088669, -0.02392948605120182, -0.04915418103337288, 0.07307549566030502, -0.17835605144500732, 0.009573044255375862, 0.010142127051949501, -0.09019022434949875, 0.18337728083133698, -0.18689659237861633, 0.060006897896528244, -0.12545537948608398, 0.05137793719768524, -0.0582728311419487, -0.038886819034814835, 0.041402388364076614, 0.039434853941202164, 0.15158191323280334, 0.04912519082427025, 0.06441680341959, 0.07815761119127274, 0.09963858127593994, -0.060166601091623306, 0.04477294534444809, -0.07033003866672516, 0.01842372864484787, -0.05095936357975006, -0.128098726272583, -0.028827829286456108, -0.028963997960090637, 0.01951354555785656, 0.012914196588099003, -0.012042518705129623, 0.0420839749276638, 0.0636172741651535, -0.022760383784770966, 0.07038886100053787, 0.12713733315467834, 0.1124449223279953, 0.06901463866233826, -0.015431778505444527, 0.0033925939351320267, -0.0709240585565567, 0.044198766350746155, -0.15550518035888672, -0.22644732892513275, -0.015578098595142365, 0.10256271809339523, -0.0654795691370964, -0.04366942495107651, -0.136142760515213, 0.01653510518372059, 0.1473275125026703, -0.027805132791399956, 0.05545593053102493, -0.03419870883226395, 0.1987011879682541, 0.18007011711597443, -0.036992147564888, 0.021121293306350708, -0.08276021480560303, 0.06062924861907959, -0.19580218195915222, -0.1167871356010437, -0.14222469925880432, 0.04652075842022896, -0.11898835748434067, -1.0081031120989792e-07, 0.06548521667718887, -0.04123573750257492, -0.04247281700372696, -0.14736713469028473, -0.06068317964673042, 0.03977183997631073, -0.08364786207675934, 0.0038024671375751495, 0.0659106895327568, 0.1284024715423584, 0.15014714002609253, 0.13422530889511108, -0.04013505205512047, 0.046578299254179, 0.0001109149307012558, -0.032361991703510284, -0.1674235463142395, -0.016421204432845116, -0.1220092922449112, -0.07473614811897278, -0.1296631395816803, -0.0020607979968190193, -0.05258701741695404, -0.028438201174139977, 0.06349638849496841, -0.10985332727432251, 0.07693985104560852, 0.06693728268146515, 0.03981444239616394, -0.22664448618888855, -0.09397650510072708, -0.03570502996444702, -0.07698982954025269, -0.015331693924963474, -0.09349792450666428, -0.13217562437057495, 0.002543974667787552, 0.12797889113426208, 0.20144778490066528, 0.08464542031288147, 0.0102075831964612, -0.024455171078443527, -0.060214340686798096, 0.008449960500001907, -0.08318488299846649, -0.024564221501350403, -0.0928165465593338, -0.03442057967185974, 0.06251019984483719, -0.1115998700261116, -0.17477215826511383, -0.10416927933692932, -0.07152979075908661, -0.05444392189383507, -0.025581084191799164, 0.17441675066947937, -0.10045205056667328, -0.1244652047753334, 0.059172745794057846, 0.0017470908351242542, -0.007529713213443756, -0.2123216986656189, 0.03767963498830795, -0.014528497122228146], "changes": {"1wk": -14.230765351176824}}, {"text": "InTheZone by Nitches Unveils January Updates, Encourages Affiliates and First Responders to Join the Mission Nitches, Inc Thu, Jan 9, 2025, 4:45 PM 2 min read In This Article: NICH -11.19% MIAMI, FL / ACCESSWIRE / January 9, 2025 / InTheZone by Nitches (OTC PINK:NICH) today announced a major website refresh at inthezonelabs.com , inviting visitors to explore a streamlined user experience, new product details, and expanded affiliate opportunities. As part of its ongoing push to reach a wider audience, InTheZone Labs will be rolling out weekly updates across TikTok, Instagram, X (formerly Twitter), and Amazon. Expanding Opportunities and Benefits Join the InTheZone Community: Potential affiliates can learn about collaboration options directly on the website's homepage. The company aims to foster a strong network of ambassadors who believe in the power of cognitive performance. Special GovX Discount: First responders, veterans, and other GovX members are eligible for a 30% discount-part of InTheZone's commitment to serving those who serve others. Product Challenge: InTheZone's nootropic formulas, tested among busy executives, parents, and frontline professionals, have shown promising results in boosting focus, clarity, and resilience. TikTok Shop Expansion In tandem with the new website launch, InTheZone by Nitches is collaborating with TikTok Shop affiliates to expand its reach in the fast-growing realm of social commerce. The brand views TikTok's rising influence as a gateway to significant nootropic market opportunities, aligning with industry forecasts of sustained growth in cognitive-enhancing solutions. \"We're just getting started in our mission to help more people get \u2018in the zone' and unlock their full potential,\" said a company spokesperson. \"We invite everyone-from working professionals to first responders-to try our products and see the benefits for themselves.\" FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. InTheZone products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. For additional updates, shareholders are encouraged to follow our progress at www.inthezonelabs.com Forward-Looking Statements: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as \"anticipates,\" \"expects,\" \"intends,\" \"plans,\" \"believes,\" \"seeks,\" \"estimates,\" and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Story Continues Contact Information John Morgan CEO info@nitchescorp.com SOURCE: Nitches, Inc View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-09T13:45:00+00:00", "sentiment": {"score": 0.7320537427440286, "confidence": 0.7402157187461853, "probabilities": {"positive": 0.7402157187461853, "negative": 0.008161976002156734, "neutral": 0.2516222894191742}}, "embedding": [-0.12933503091335297, -0.06317611038684845, -0.007758349645882845, -0.0674285963177681, 0.09724518656730652, -0.031339988112449646, 0.06262651830911636, 0.15327516198158264, -0.010960925370454788, 0.10064102709293365, -0.0025180529337376356, -0.003062437055632472, 0.10687731206417084, -0.01569623313844204, 0.09249921888113022, -0.019375473260879517, 0.11578840017318726, -0.10403729975223541, -0.19587358832359314, -0.06474874168634415, -0.011769925244152546, -0.06896378099918365, 0.01554383710026741, -0.0727197676897049, -0.17554903030395508, -0.006116088479757309, -0.09041326493024826, -0.010688278824090958, -0.085237517952919, -0.0841248631477356, 0.018447399139404297, 0.16912251710891724, 0.0022046170197427273, -0.04155862331390381, -0.06222263723611832, -0.023022552952170372, -0.0903078094124794, -0.016283957287669182, -0.11773110181093216, -0.05213925614953041, -0.039521727710962296, -0.09248568117618561, -0.0999046117067337, 0.044800907373428345, -0.04801540821790695, -0.07910424470901489, -0.04399476572871208, 0.0654926598072052, -0.05459576100111008, 0.06814022362232208, -0.0868939608335495, -0.13856825232505798, 0.031621210277080536, 0.055556584149599075, 0.0034923257771879435, 0.0181678868830204, -0.1976226419210434, -0.020359061658382416, -0.09065146744251251, -0.015066704712808132, 0.08214999735355377, -0.14410707354545593, 0.0014224089682102203, 0.07879084348678589, 0.06811009347438812, 0.06818632036447525, -0.007377739064395428, 0.056836701929569244, -0.11794557422399521, -0.07469066977500916, 0.00649880850687623, -0.051510583609342575, -0.10123279690742493, 0.11438077688217163, 0.043746232986450195, 0.09912703931331635, 0.265433669090271, 0.04406169056892395, 0.09567581117153168, -0.15250462293624878, 0.014849558472633362, 0.15353015065193176, 0.08333630859851837, -0.01012581679970026, -0.07323507964611053, 0.02179025113582611, 2.591218799352646e-05, 0.15204882621765137, 0.05654104799032211, 0.032386425882577896, 0.06272061169147491, 0.026419349014759064, -0.051055196672677994, -0.06376168876886368, 0.01103321835398674, -0.05783830210566521, -0.07831303775310516, -0.000797932967543602, -0.08817832171916962, 0.09438596665859222, 0.0840587466955185, 0.04046470671892166, -0.01836836151778698, -0.09270034730434418, -0.09986463189125061, -0.039420679211616516, 0.04243801534175873, 0.080403171479702, 0.10534300655126572, 0.11568203568458557, -0.19873294234275818, -0.00029553123749792576, 0.0742640346288681, 0.0022323853336274624, -0.08294138312339783, -0.004357526078820229, -0.02685188502073288, 0.051486022770404816, 0.2593093514442444, -0.08328452706336975, 0.09060096740722656, 0.11550159752368927, 0.042851075530052185, -0.010322727262973785, -0.014240428805351257, 0.08622311055660248, -0.06451234221458435, 9.059139701811906e-33, -0.1119440495967865, 0.17494946718215942, -0.00889550894498825, -0.04894218593835831, 0.004128545522689819, 0.009704042226076126, 0.003713941900059581, 0.01878725364804268, -0.11762163788080215, 0.004560536704957485, -0.10842666029930115, 0.1939835250377655, -0.03821612522006035, 0.1600888967514038, 0.03748205304145813, -0.05336294323205948, -0.06558167934417725, 0.050540436059236526, -0.05236220359802246, 0.02480354718863964, 0.044092897325754166, 0.01468681637197733, -0.09057535231113434, 0.05598660558462143, -0.02313312515616417, 0.08699047565460205, 0.03235230967402458, 0.048713356256484985, 0.034896641969680786, 0.03724607825279236, -0.11408600211143494, -0.043766871094703674, 0.040858231484889984, -0.09234447777271271, -0.05118929222226143, -0.08149714022874832, 0.08184903115034103, -0.11846539378166199, 0.02239934727549553, -0.08186019957065582, -0.1437389850616455, 0.05824316293001175, -0.14695169031620026, 0.03341766446828842, -0.036093663424253464, -0.01239449717104435, 0.0598611906170845, -0.010504812002182007, 0.0920402780175209, -0.030678842216730118, -0.04611603170633316, 0.0005416572093963623, 0.06053140014410019, -0.11850787699222565, -0.10862787067890167, 0.05876123905181885, -0.05732577294111252, -0.08954721689224243, 0.13397011160850525, -0.024449976161122322, 0.04245573282241821, -0.025334767997264862, -0.04565690457820892, -0.038194335997104645, -0.07726851850748062, 0.01065870001912117, 0.02236337587237358, 0.0011406985577195883, -0.04870680719614029, 0.014450088143348694, -0.012487135827541351, 0.038384996354579926, 0.08895403891801834, -0.04813984036445618, 0.04769303649663925, 0.007155707571655512, -0.02997666969895363, 0.0141623979434371, 0.03490985557436943, -0.01447337307035923, 0.018183132633566856, -0.018417295068502426, -0.016153767704963684, -0.0033402997069060802, 0.06390926241874695, -0.012070510536432266, 0.04463560879230499, -0.012124070897698402, -0.06679272651672363, -0.021364815533161163, 0.076774001121521, 0.03507425636053085, -0.03329828754067421, 0.14070624113082886, -0.05243910104036331, -8.309923683635936e-33, -0.10794229805469513, -0.008777957409620285, -0.1941625475883484, 0.05901707708835602, 0.09696061909198761, 0.07557185739278793, 0.12448745965957642, -0.051200009882450104, 0.08768381178379059, -0.12477609515190125, -0.0463271290063858, 0.04575522989034653, -0.043684933334589005, -0.04139668494462967, 0.03359554335474968, -0.029179904609918594, 0.07579323649406433, 0.006903158035129309, -0.09964069724082947, -0.06193336844444275, -0.0053913407027721405, 0.08503591269254684, -0.14948688447475433, 0.02983330748975277, -0.006956252735108137, 0.12214750051498413, 0.0780496820807457, 0.12215416133403778, -0.06662619113922119, 0.04329048842191696, -0.016646694391965866, -0.06253719329833984, -0.16318435966968536, 0.06706756353378296, 0.06270203739404678, 0.040313076227903366, -0.008341015316545963, -0.1386294811964035, -0.10131078213453293, -0.016682878136634827, 0.008697320707142353, 0.01294616237282753, -0.06245996803045273, 0.04551825672388077, -0.08305211365222931, 0.08776865154504776, -0.07215858995914459, -0.12162105739116669, -0.06728415936231613, 0.08385862410068512, 0.013531235978007317, 0.07954885065555573, 0.003717707470059395, 0.05069108307361603, -0.0967659130692482, 0.05284838750958443, 0.0376863069832325, -0.04046206176280975, -0.022213134914636612, 0.05528829246759415, 0.008120574988424778, 0.12729741632938385, -0.01167946308851242, 0.016121480613946915, 0.10503889620304108, -0.03600587323307991, 0.0579124391078949, 0.06491836905479431, 0.013947504572570324, -0.015230109915137291, 0.07750842720270157, 0.0006807167083024979, -0.11399999260902405, -0.25181353092193604, -0.046587023884058, 0.03512774035334587, 0.0749153345823288, -0.024063367396593094, -0.16750358045101166, -0.10375574231147766, -0.10083526372909546, 0.039839968085289, 0.09340585768222809, -0.010709572583436966, -0.038620270788669586, 0.043195951730012894, 0.012293681502342224, 0.13605599105358124, -0.03263170272111893, 0.042291149497032166, -0.06792750954627991, 0.039059385657310486, -0.2215440571308136, 0.25528189539909363, 0.03175455331802368, -1.0054014865090721e-07, 0.033912405371665955, -0.05705604702234268, -0.09458355605602264, 0.05958078056573868, 0.06705066561698914, -0.047121673822402954, -0.0018839668482542038, 0.06232989579439163, -0.01438444945961237, 0.2020280659198761, 0.16297125816345215, 0.006318148225545883, -0.05231437087059021, 0.08913351595401764, 0.07758687436580658, 0.06412678956985474, 0.0926111713051796, 0.026049213483929634, -0.09479661285877228, -0.06864878535270691, -0.03482591360807419, 0.10922257602214813, 0.01103191077709198, -0.19383588433265686, 0.0271504707634449, -0.009910942986607552, -0.0906364917755127, 0.04041758179664612, 0.040578607469797134, -0.0030415356159210205, -0.09478123486042023, 0.05956060439348221, -0.03736601769924164, 0.006988472770899534, -0.011304741725325584, -0.020217202603816986, 0.047153256833553314, 0.07453702390193939, 0.0654492974281311, 0.006659198552370071, -0.020446307957172394, 0.11123888194561005, 0.09807439893484116, 0.0390111580491066, -0.024976946413517, -0.08089123666286469, -0.06793913245201111, -0.13058435916900635, 0.12558630108833313, -0.06255612522363663, -0.1210828423500061, 0.053089968860149384, -0.03596426546573639, 0.04361208155751228, 0.0009580678306519985, -0.00962131004780531, -0.08242879807949066, 0.006212511565536261, 0.023006295785307884, 0.10060407221317291, 0.13941942155361176, -0.08657713234424591, 0.0367964468896389, 0.02638242579996586], "changes": {"1wk": 0.8968601235628331}}, {"text": "GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025 NewMediaWire Wed, Jan 8, 2025, 5:00 PM 3 min read In This Article: GOVX -7.33% GOVXW -22.92% Company to provide updates on progress toward the BARDA-funded Phase 2b trial of GEO-CM04S1, its next-generation COVID-19 vaccine as well as for Gedeptin (R) (solid tumor therapy) and GEO-MVA (Mpox/Smallpox vaccine) ATLANTA, GA - January 8, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, is pleased to announce that it has been invited to present at the next Emerging Growth Conference being held January 15-16, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman and CEO, David Dodd, in real time. Mr. Dodd will be presenting at 2:35 pm ET on Thursday, January 16, 2025, reviewing the Company's 2024 progress. Following his presentation, Mr. Dodd will open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Dodd will do his best to get through as many of them as possible. Please register here to ensure you are able to attend the conference and receive any updates that are released. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference . About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world's most threatening infectious diseases and therapies for solid tumor cancers. The company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin(R) combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com . Story Continues Company Contact: Investor Relations Contact: Media Contact: info@geovax.com austin.murtagh@precisionaq.com sr@roberts-communications.com 678-384-7220 212-698-8696 202-779-0929 View the original release on www.newmediawire.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-08T14:00:00+00:00", "sentiment": {"score": 0.08831251878291368, "confidence": 0.09798038750886917, "probabilities": {"positive": 0.09798038750886917, "negative": 0.009667868725955486, "neutral": 0.8923517465591431}}, "embedding": [-0.09733060747385025, -0.10752270370721817, 0.11045017838478088, -0.1074502170085907, -5.0053640734404325e-06, -0.053386956453323364, -0.010274570435285568, 0.015781566500663757, -0.05324286222457886, 0.06468263268470764, -0.13094280660152435, 0.05985257774591446, 0.11210964620113373, 0.08680678904056549, -0.12351463735103607, -0.02373667061328888, 0.06460555642843246, -0.11593573540449142, -0.04716258496046066, 0.08627331256866455, -0.034701474010944366, -0.052313320338726044, 0.034949835389852524, 0.01846853829920292, -0.13441826403141022, 0.02552524022758007, -0.10769262909889221, -0.058958761394023895, -0.081955187022686, 0.00060271006077528, 0.014954688027501106, 0.0426800474524498, -0.03010912425816059, -0.10010536015033722, -0.06105376034975052, 0.03205382078886032, 0.01995806023478508, 0.03938503563404083, -0.07888267189264297, 0.07184110581874847, -0.00737009197473526, -0.11658866703510284, 0.009065774269402027, 0.0750979408621788, 0.12966474890708923, -0.17205394804477692, -0.06451664865016937, -0.0638471320271492, 0.04221704602241516, 0.13216671347618103, -0.13625386357307434, -0.306571364402771, -0.03843224421143532, 0.09483008086681366, -0.036355577409267426, -0.036233264952898026, -0.1616782695055008, -0.05802243947982788, 0.0825471431016922, -0.0770173966884613, 0.010048206895589828, -0.17141012847423553, -0.05480284243822098, 0.11380941420793533, 0.10114584118127823, 0.0510936938226223, 0.13230586051940918, 0.04346681013703346, -0.0035561230033636093, -0.1184903010725975, -0.006683394778519869, 0.11145885288715363, -0.06346654146909714, 0.017343830317258835, -0.05858945846557617, 0.23327268660068512, 0.10546988993883133, 0.08268223702907562, 0.3059661388397217, -0.051152341067790985, 0.11129303276538849, 0.07363151758909225, 0.10187500715255737, 0.009511488489806652, -0.069520965218544, 0.037456534802913666, 0.05807666480541229, 0.11088952422142029, 0.09474176168441772, -0.04302964732050896, 0.10496577620506287, 0.11009055376052856, 0.01671167090535164, 0.1289137452840805, -0.05680494010448456, -0.030618976801633835, -0.04331309348344803, -0.02428790181875229, 0.13576194643974304, 0.004984995350241661, 0.038346778601408005, -0.0836777463555336, -0.12314234673976898, -0.045961469411849976, -0.10128156840801239, -0.08247910439968109, -0.05079690366983414, 0.06210995465517044, 0.015150157734751701, 0.03566848114132881, -0.18624693155288696, 0.2250877171754837, 0.04812262952327728, -0.08449845016002655, -0.12899506092071533, 0.33639442920684814, -0.040744125843048096, 0.002332533709704876, 0.08823429048061371, -0.1750197857618332, 0.05130235105752945, -0.09250836074352264, -0.012035573832690716, -0.10488497465848923, 0.09095986187458038, -0.0030794059857726097, 0.028670575469732285, 6.187751569534642e-33, 0.051510393619537354, -0.021195797249674797, 0.1342877745628357, 0.1126648336648941, 0.028791675344109535, 0.13387629389762878, 0.007606944069266319, -0.015974201261997223, -0.20259295403957367, -0.10298275202512741, -0.15037420392036438, 0.09137612581253052, 0.03161178156733513, 0.10438671708106995, -0.07271365076303482, -0.06238676235079765, -0.024124272167682648, 0.05171351134777069, -0.09834945201873779, 0.06337186694145203, 0.037761904299259186, 0.06373146176338196, 0.04586848244071007, 0.1570362150669098, 0.08026178181171417, 0.14597360789775848, -0.06312690675258636, 0.018556585535407066, -0.021824117749929428, 0.05671229586005211, -0.12770098447799683, -0.05531368404626846, -0.06701289117336273, 0.0017378386110067368, -0.022648625075817108, -0.02887505665421486, -0.12078332901000977, -0.18317486345767975, 0.04585373401641846, -0.020463649183511734, -0.02091263048350811, 0.09411565214395523, -0.05224340036511421, -0.10880004614591599, 0.07297777384519577, -0.14896486699581146, -0.019075069576501846, -0.07266910374164581, 0.07762611657381058, 0.039350125938653946, 0.02530517429113388, 0.1556871235370636, -0.14229515194892883, -0.07723385095596313, 0.08051463961601257, 0.03799083083868027, -0.001593656837940216, 0.0254269540309906, 0.08442164212465286, 0.13172319531440735, 0.07181651890277863, 0.15356723964214325, -0.0695103108882904, 0.001318338792771101, -0.09197735041379929, -0.01585346832871437, -0.02534882351756096, -0.04796797037124634, -0.03300026059150696, 0.09842650592327118, 0.03779367357492447, 0.03210136294364929, 0.04423544555902481, -0.06515543162822723, 0.0890260636806488, -0.1261547952890396, 0.07134197652339935, -0.006788210012018681, -0.01606849581003189, 0.11023461818695068, -0.07988901436328888, 0.0021182834170758724, -0.013239353895187378, 0.1484600156545639, -0.10108999907970428, -0.08562864363193512, 0.051129065454006195, 0.10307334363460541, -0.16098061203956604, -0.00877752061933279, 0.07275725901126862, 0.0009438199922442436, -0.009661695919930935, 0.084927998483181, 0.007290075533092022, -8.343412048322924e-33, -0.04543287307024002, -0.05111623555421829, -0.07215669751167297, -0.04992162808775902, -0.07742594182491302, 0.005173739045858383, 0.14046066999435425, -0.030599482357501984, 0.1172190010547638, -0.1126565933227539, 0.08759361505508423, 0.19049513339996338, 0.037629734724760056, 0.0964106097817421, -0.08532626926898956, -0.04452221840620041, 0.02002318762242794, -0.15495312213897705, -0.1757374107837677, -0.03811686113476753, 0.0986466258764267, 0.16891542077064514, -0.056744471192359924, -0.015535429120063782, -0.027513522654771805, 0.016898266971111298, 0.19765791296958923, 0.14674386382102966, 0.058720801025629044, -0.030238308012485504, -0.08291785418987274, 0.03656511753797531, -0.21925514936447144, 0.06092892587184906, 0.06999979168176651, -0.07265177369117737, 0.20082005858421326, -0.17106905579566956, 0.044163480401039124, -0.15883399546146393, 0.043081432580947876, 0.014544973149895668, -0.05141343176364899, 0.03744756057858467, 0.05643998831510544, 0.18818196654319763, 0.08720208704471588, 0.11541692912578583, 0.0616319365799427, 0.12625694274902344, -0.0631447285413742, -0.0076440381817519665, -0.05135916918516159, -0.0008774681482464075, -0.01761621981859207, -0.06501045823097229, -0.027805037796497345, -0.08132591098546982, -0.0006332863122224808, 0.03130974620580673, -0.002924308180809021, 0.06264069676399231, 0.05598299577832222, -0.03464379534125328, 0.046242550015449524, 0.19711031019687653, 0.11039154976606369, 0.10740794241428375, 0.027513261884450912, -0.0014434801414608955, -0.05021839588880539, 0.04721559211611748, -0.10939750075340271, -0.22912144660949707, -0.011977868154644966, 0.05304735153913498, -0.026164166629314423, -0.006091362796723843, -0.07775876671075821, -0.045447930693626404, 0.052433326840400696, 0.01492338627576828, 0.11048456281423569, -0.030984576791524887, 0.20518478751182556, 0.1921381652355194, -0.02083001658320427, -0.01917188987135887, -0.030346449464559555, 0.06734670698642731, -0.20946604013442993, -0.10661529004573822, -0.08086574077606201, 0.046765197068452835, -0.008431660011410713, -1.0041026143881027e-07, 0.05990391969680786, 0.007478203158825636, -0.046752214431762695, -0.13882938027381897, -0.0021374195348471403, 0.000460292212665081, -0.10793345421552658, -0.020705783739686012, 0.09383813291788101, 0.12249597907066345, 0.18278852105140686, 0.1292852759361267, -0.02979700267314911, 0.036055512726306915, 0.01715874671936035, -0.0046014063991606236, -0.1644178032875061, -0.028050485998392105, -0.16678063571453094, -0.12948927283287048, -0.07368607819080353, -0.019731709733605385, 0.0007820054888725281, -0.018769677728414536, 0.06712780892848969, -0.10897815227508545, 0.08371557295322418, 0.07312285900115967, -2.3020431399345398e-05, -0.23243418335914612, -0.07612467557191849, -0.04385478422045708, -0.08553821593523026, -0.03146269544959068, -0.10697054117918015, -0.08826605975627899, 0.03169053792953491, 0.17154596745967865, 0.23107272386550903, 0.11514818668365479, -0.01860547997057438, 0.016060004010796547, -0.01060787308961153, -0.022241733968257904, -0.05101943016052246, -0.017073646187782288, -0.12813422083854675, -0.10397255420684814, 0.0462251752614975, -0.12162251770496368, -0.14959949254989624, -0.09427206963300705, -0.09383942186832428, -0.04344107210636139, -0.03037179447710514, 0.14311346411705017, -0.06701469421386719, -0.09760911762714386, 0.08843372762203217, -0.04179538041353226, -0.09441515803337097, -0.2109767347574234, -0.03166275843977928, 0.030239805579185486], "changes": {"1wk": -4.090915938054087}}, {"text": "How Nitches Inc, Wholy Owned Subsidiary InTheZone Labs Inspired a Team of Scientists, Biochemists and Researchers to Formulate a Breakthrough Next-Level Nootropic Nitches, inc Fri, Jan 3, 2025, 5:00 PM 4 min read In This Article: NICH -11.19% MIAMI, FLORIDA / ACCESSWIRE / January 3, 2025 / Nitches Inc (OTC PINK:NICH) How Nitches Inc, wholly owned subsidiary InTheZone Labs inspired a team of scientists, biochemists and researchers to Formulate a Breakthrough Next-Level Nootropic that's Empowering Driven Individuals to Dominate Deadlines and Demanding Tasks After Discovering This Blend, It Was Shared With 33 Hardworking Individuals From All Walks of Life-93% Reported Extreme Focus, Enhanced Memory, and Elevated Productivity. InTheZone has officially unveiled a nootropic blend that could redefine how entrepreneurs, students, and even former NFL players power through grueling days. Spearheaded by a biochemist and neuroscientist and inspired by the relentless schedule of a seasoned entrepreneur, this premium blend merges high-impact ingredients like L-theanine, alpha-GPC, lion's mane mushrooms, and phosphatidylserine-each scientifically linked to boosted cognition and calm concentration. With global nootropic markets projected to exceed $10 billion in the coming years, Nitches Inc., wholly owned subsidiary \"InTheZone Labs\" stands to benefit from a rapid expansion. In a 33-participant phase 1 study, 93% reported improvements in memory, focus, and overall productivity. This 93% of reported improvements were based on a detailed study and feedback report from each individual that participated. Then these numbers, calculations and answers were then entered into Artificial Intelligence in order to give us the specific percentage of improvements which is 93%. The study spanned a diverse test group-venture capitalists, college students, veterans, and high-ranking professionals - offering a preview of the broad consumer appeal. Key Takeaways from the Phase 1 Study and Results: \u2022 Immediate Focus, Zero Crash: A consistent theme among participants was calm, laser-focused attention without caffeine-induced jitters. Former NFL pros praised the supplement for its ability to sustain mental clarity even on demanding schedules. \u2022 Customizable Dosages: Bigger-bodied testers - over 6'2\" and 200 lbs - experienced optimal benefits at three capsules, with 78% of female trial participants noting marked stress relief and mood balance at standard dosages. \u2022 Real Science, Real Results: Leveraging proven nootropic ingredients, InTheZone users discovered a sustainable alternative to prescription stimulants. Notably, testers with high-stress roles - like neurosurgeons - reported newfound clarity and fewer side effects. \u2022 Broad Lifestyle Integration: Students tackling finals credited InTheZone for sharper concentration under deadline pressure. Parents reported smoother multitasking, citing decreased irritability. Story Continues \"This isn't about a quick thrill. It's about amplifying the best in you - sustainably, consistently, and without compromise,\" stated one of the biochemists behind the formula. Availability Both InTheZone Youth and InTheZone Focused Extreme are now available on Amazon and the TikTok Shop. Market Outlook The surge in demand for natural cognitive enhancers creates a ripe environment for InTheZone. With both InTheZone Youth and InTheZone Focused Extreme available on Amazon and TikTok Shop - and a special GovX discount for veterans and first responders-company insiders project swift market penetration. As more professionals pivot to cleaner, science-backed strategies for mental performance, early indicators suggest InTheZone could emerge as a strong contender in the evolving nootropic space. FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with your healthcare provider before starting any new dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition. For additional updates, shareholders are encouraged to follow our progress at www.inthezonelabs.com Forward-Looking Statements: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as \"anticipates,\" \"expects,\" \"intends,\" \"plans,\" \"believes,\" \"seeks,\" \"estimates,\" and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Contact Information John Morgan Ceo info@nitchescorp.com SOURCE: Nitches, inc View the original press release on accesswire.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2025-01-03T14:00:00+00:00", "sentiment": {"score": 0.29418077785521746, "confidence": 0.3058440089225769, "probabilities": {"positive": 0.3058440089225769, "negative": 0.011663231067359447, "neutral": 0.6824927926063538}}, "embedding": [0.025785371661186218, -0.060099128633737564, -0.0008668103255331516, 0.06796720623970032, 0.05697733163833618, -0.036301180720329285, 0.010023274458944798, 0.1321072280406952, 0.05131892114877701, 0.07624687999486923, -0.10851235687732697, -0.026075897738337517, -0.04201620817184448, 0.027266422286629677, -0.08556853234767914, 0.019848652184009552, 0.06728444248437881, -0.015568801201879978, -0.20839005708694458, -0.011561274528503418, -0.009322776459157467, -0.05636754631996155, 0.0809665098786354, 0.0488799586892128, -0.15693461894989014, 0.13682323694229126, -0.14869815111160278, -0.06268560886383057, -0.13666553795337677, -0.14585629105567932, 0.09430944174528122, 0.13758040964603424, 0.036160342395305634, -0.06591533124446869, 0.001517917262390256, -0.017892440780997276, -0.07150562852621078, 0.16110548377037048, -0.08452914655208588, -0.02370763197541237, -0.0875883549451828, -0.1097053736448288, -0.05396181344985962, 0.08612990379333496, -0.09428223222494125, -0.09925425052642822, -0.07962428033351898, -0.03989392891526222, 0.006203452590852976, 0.045124638825654984, -0.2340129315853119, -0.18091027438640594, 0.053054288029670715, -0.03810392692685127, 0.09140324592590332, 0.15683406591415405, -0.12020689994096756, 0.013634216040372849, -0.09376760572195053, 0.08107365667819977, 0.013996083289384842, -0.0729093849658966, -0.013262324035167694, -0.05368715524673462, 0.11744983494281769, 0.11070337891578674, 0.014060999266803265, -0.06615613400936127, -0.0812080129981041, -0.04342815279960632, 0.09852904081344604, -0.10739226639270782, 0.012072961777448654, -0.01693974807858467, 0.07005596160888672, 0.25507301092147827, 0.10527748614549637, 0.037169262766838074, 0.153906911611557, -0.044125571846961975, 0.09142137318849564, 0.11717864871025085, 0.016730455681681633, 0.03154986351728439, -0.023288404569029808, 0.023607052862644196, -0.013683417811989784, 0.13990440964698792, 0.05558237433433533, 0.061370715498924255, 0.0012416467070579529, -0.05893968790769577, -0.057939864695072174, -0.07416775077581406, 0.03676158934831619, -0.02332267537713051, -0.09442228078842163, 0.0339832529425621, -0.051021404564380646, 0.0460001640021801, 0.06715265661478043, 0.03338123857975006, -0.06476904451847076, -0.06240220367908478, -0.07549640536308289, -0.0648016408085823, 0.08841602504253387, 0.010447533801198006, 0.1098988950252533, 0.15104126930236816, -0.10861162841320038, 0.049115829169750214, -0.03639337420463562, 0.09631381183862686, -0.0013139010407030582, 0.09971405565738678, -0.03859659656882286, 0.015159646049141884, 0.11705484986305237, 0.022290315479040146, 0.1238773763179779, 0.007868073880672455, 0.0654822587966919, -0.05428158491849899, -0.062439803034067154, 0.0955091193318367, -0.04993772879242897, 9.640732429612526e-33, 0.0052923783659935, 0.10384595394134521, -0.06551595777273178, 0.092062808573246, 0.005472901277244091, -0.08162632584571838, -0.049429140985012054, 0.04514859989285469, -0.040408238768577576, -0.07416757196187973, -0.049904223531484604, 0.14234434068202972, -0.10018493980169296, 0.14257077872753143, 0.033674273639917374, -0.0837375745177269, -0.13242581486701965, 0.06239040940999985, -0.032739974558353424, 0.03423386439681053, -0.008789841085672379, 0.08080974966287613, -0.09010149538516998, 0.02326756715774536, -0.04319625347852707, 0.08089098334312439, -0.16976270079612732, -0.023725805804133415, 0.009655708447098732, 0.01747904159128666, -0.08374911546707153, -0.02267826907336712, -0.08294689655303955, -0.05917792394757271, -0.08910325169563293, -0.05137979984283447, 0.04666779190301895, -0.15232573449611664, 0.08039258420467377, 0.08174753934144974, -0.09718567132949829, 0.09769326448440552, -0.0060277520678937435, -0.051609158515930176, -0.01642807386815548, 0.031863436102867126, 0.004319700878113508, 0.05502967908978462, 0.007715069223195314, -0.006778375245630741, -0.012988043017685413, 0.03867056593298912, 0.1141100823879242, -0.12075203657150269, -0.07272092998027802, 0.030629586428403854, -0.08514413237571716, -0.11931175738573074, 0.08637996017932892, -0.020425401628017426, 0.07694833725690842, 0.103775754570961, -0.09618520736694336, 0.015438773669302464, 0.017892619594931602, 0.00473130214959383, -0.043049946427345276, 0.02784242108464241, 0.027216602116823196, 0.11776672303676605, 0.02913621813058853, -0.02851809561252594, 0.08704443275928497, -0.05041653662919998, 0.10138899087905884, -0.07010088860988617, -0.06079546734690666, 0.06374135613441467, -0.07181289792060852, -0.05929990112781525, 0.19380977749824524, 0.029543962329626083, -0.16802580654621124, -0.03458959609270096, -0.012947091832756996, 0.07433225214481354, 0.041189588606357574, 0.09942024946212769, -0.11706896126270294, -0.12915359437465668, 0.020772911608219147, -0.1349034160375595, 0.0024059247225522995, -0.014629142358899117, -0.11890952289104462, -7.680778535924708e-33, -0.04875730723142624, -0.18502545356750488, -0.06639884412288666, 0.03550207242369652, 0.18969440460205078, 0.0950605720281601, 0.056402403861284256, -0.14835774898529053, -0.013275988399982452, -0.09126792103052139, 0.008785470388829708, 0.0275539793074131, 0.01560763269662857, -0.03824888542294502, -0.0645180344581604, -0.11554722487926483, -0.0286732017993927, 0.07733273506164551, -0.029206419363617897, -0.09937802702188492, 0.04241336137056351, 0.1158270314335823, -0.14963313937187195, 0.023965660482645035, 0.03445816412568092, 0.15255936980247498, 0.05023007467389107, 0.11263731122016907, 0.05097053945064545, 0.07681326568126678, -0.02869855985045433, 0.1512754112482071, -0.1516922414302826, -0.024356890469789505, 0.11635354161262512, 0.12650184333324432, -0.12258584797382355, -0.08901713788509369, -0.14610663056373596, -0.14940527081489563, 0.01051463931798935, 0.09357303380966187, -0.0022039320319890976, 0.09543077647686005, 0.07428081333637238, 0.07039180397987366, -0.09739129990339279, -0.1268644630908966, -0.035061225295066833, 0.13645803928375244, 0.12701302766799927, 0.07864102721214294, -0.09477511048316956, -0.03095262125134468, -0.03984736651182175, -0.03777162730693817, 0.013035684823989868, -0.14312349259853363, -0.03682523965835571, -0.04526307433843613, -0.09291207790374756, 0.042575906962156296, -0.10523416101932526, 0.016033202409744263, 0.006122525781393051, 0.03623904287815094, 0.05143363028764725, 0.08039845526218414, -0.0027486737817525864, -0.013212570920586586, -0.046492598950862885, -0.03550245612859726, 0.07046821713447571, -0.14679807424545288, -0.034925345331430435, 0.10742553323507309, -0.022962842136621475, -0.02473514713346958, -0.06501272320747375, -0.03788704797625542, -0.16362884640693665, -0.08505579829216003, 0.0646180808544159, 0.03655878081917763, 0.057372547686100006, 0.09390464425086975, -0.047125495970249176, 0.13079196214675903, -0.010704842396080494, 0.03333436697721481, -0.024239081889390945, -0.08501918613910675, -0.2097192108631134, 0.09791616350412369, 0.022650111466646194, -1.004694141215623e-07, 0.20370060205459595, -0.04366970434784889, -0.0014293398708105087, 0.06460708379745483, 0.064967080950737, -0.08735401928424835, -0.002558681648224592, 0.03951701521873474, 0.00937894731760025, 0.18808047473430634, 0.15281030535697937, 0.12034005671739578, -0.0475626178085804, 0.13904495537281036, 0.07112667709589005, 0.11384327709674835, 0.12062293291091919, 0.09333014488220215, -0.06216147169470787, 0.026856819167733192, -0.05665399879217148, 0.03885860741138458, -0.08750590682029724, -0.16503790020942688, -0.033097997307777405, -0.09114342927932739, 0.0270647294819355, 0.03376735374331474, 0.01931718736886978, 0.022051945328712463, 0.035181205719709396, 0.029518229886889458, -0.0331859290599823, -0.022614890709519386, 0.00840770173817873, -0.12677083909511566, 0.1403346210718155, 0.04120299965143204, -0.013041901402175426, 0.06463120877742767, -0.08531380444765091, 0.02060968056321144, -0.014448915608227253, 0.10512105375528336, -0.006539084017276764, -0.13525696098804474, -0.199403777718544, -0.099575474858284, 0.05382898449897766, -0.02580663561820984, -0.0035709841176867485, 0.12952256202697754, -0.01356978714466095, 0.011462021619081497, -0.1027945876121521, 0.06200801581144333, -0.0189475417137146, 0.03090251237154007, -0.13693895936012268, -0.07434685528278351, 0.1947142630815506, -0.010251123458147049, 0.07909631729125977, 0.022245317697525024], "changes": {"1wk": -16.666668171834402, "1mo": -27.65151929072643}}, {"text": "GOVX and NASCAR Announce Official Partnership PR Newswire Tue, Dec 10, 2024, 8:00 PM 4 min read As part of the multi-year agreement, GOVX will serve as the Presenting Sponsor of the NASCAR Miltix program DAYTONA BEACH, Fla. , Dec. 10, 2024 /PRNewswire/ -- NASCAR and GOVX, the online shopping platform exclusively for current and former military, first responders, emergency medical professionals, educators, and other government service personnel, announced today an official multi-year partnership that strengthens NASCAR's longstanding commitment to the military and first responder communities. Official Partner of NASCAR Through this new partnership, GOVX will serve as the Presenting Sponsor and Official Verification Partner of the NASCAR Miltix program, offering discounted race tickets of 15% off or more to NASCAR-owned tracks nationwide. Eligible service members will be able to access this benefit through both NASCAR.com and GOVX.com. First responders and other Americans of service will also be eligible to receive the ticket discount offering through the partnership. With an existing membership of over 9.5M , GOVX will help to amplify NASCAR's commitment to this deserving community. \"Since the inception of our sport, honoring members of the military has been a big piece of the fabric that makes up\u00a0NASCAR and, in partnership with GOVX, the Miltix program is one of many ways we're able to do that,\" said Michelle Byron , NASCAR Executive Vice President, Chief Partnership and Licensing Officer. \"There is nothing better than the at-track NASCAR experience, and thanks to GOVX and the Miltix program, it's even easier for current and former members of the military to access that experience.\" The Official Partnership will also be supported through robust promotion on GOVX.com, GOVX signage at NASCAR tracks throughout the race season, commercial inventory within NASCAR TV broadcasts, and through NASCAR.com and other digital media placements. \"Over the decades, NASCAR has shown an unwavering appreciation and dedication to our nation's heroes, both on the track and off,\" said Alan Cole , GOVX CEO. \"The opportunity to partner with such a prestigious organization is a privilege, and we look forward to bringing the pulse of America's racing spirit to the GOVX community.\" NASCAR has a long-tenured and deep-seated appreciation for the military through initiatives such as the annual NASCAR Salutes and Troops to the Track programs, a partnership with Honor and Remember and supporting the mission of Sound Off, a nonprofit organization founded to help reduce veteran suicide through free and anonymous mental health support for veterans and service members. Story continues ABOUT NASCAR The National Association for Stock Car Auto Racing (NASCAR) is the sanctioning body for the No. 1 form of motorsports in the United States and owner of 14 of the nation's major motorsports entertainment facilities. NASCAR sanctions races in three national series (NASCAR Cup Series\u2122, NASCAR Xfinity Series\u2122, and NASCAR CRAFTSMAN Truck Series\u2122), four international series (NASCAR Brasil Series, NASCAR Canada Series, NASCAR Mexico Series, NASCAR Whelen Euro Series), four regional series (ARCA Menards Series, ARCA Menards Series East & West and the NASCAR Whelen Modified Tour) and a local grassroots series (NASCAR Advance Auto Parts Weekly Series). The International Motor Sports Association\u2122 (IMSA\u00ae) governs the IMSA WeatherTech SportsCar Championship\u2122, the premier U.S. sports car series. NASCAR also owns Motor Racing Network, Racing Electronics, and ONE DAYTONA . Based in Daytona Beach, Florida , with offices in five cities across North America , NASCAR sanctions more than 1,200 races annually in 11 countries and more than 30 U.S. states. For more information visit www.NASCAR.com and www.IMSA.com , and follow NASCAR on Instagram, YouTube, Facebook, X and Snapchat. ABOUT GOVX GOVX is dedicated to serving those who serve our country and communities \u2013 military service members, first responders, law enforcement officers, emergency medical professionals, educators, and other government service personnel. With a customizable suite of solutions, GOVX provides leading brands who share in our mission with a unique opportunity to support this deserving audience. Through our flagship ecommerce site, GOVX.com, brands can authentically reach a growing community of 9.5M+ members with their own storefront. More than 1K trusted brands currently have a storefront on GOVX.com, offering unbeatable deals to those who serve. With our verification app, GOVX ID, brands can easily enable service member discounts within the checkout flow of their own sites. More than 3K brands currently utilize our GOVX ID technology to honor service members. By leveraging GOVX marketing services solutions, brands can effectively amplify their products or services within our engaged and exclusive community and reinforce their support for Americans who make a difference. In addition to providing unmatched value to those who serve, GOVX also donates a portion of every order to nonprofits who serve the military and first responder community. To-date we have donated more than $1.5M through our GOVX Gives Back initiative. For more information, visit https://www.govx.com . Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/govx-and-nascar-announce-official-partnership-302326845.html SOURCE GOVX View comments Terms and Privacy Policy Privacy Dashboard Recommended stories", "symbol": "GOVX", "date": "2024-12-10T17:00:00+00:00", "sentiment": {"score": 0.5927428100258112, "confidence": 0.6030112504959106, "probabilities": {"positive": 0.6030112504959106, "negative": 0.01026844047009945, "neutral": 0.38672029972076416}}, "embedding": [-0.18865753710269928, -0.03487477824091911, 0.08418326824903488, -0.025388402864336967, 0.0004640500992536545, 0.15022572875022888, 0.018031662330031395, 0.07599270343780518, 0.044129543006420135, -0.02760518714785576, -0.12558598816394806, 0.04558297619223595, 0.06558531522750854, 0.07746719568967819, 0.020213328301906586, -0.18179598450660706, 0.13453960418701172, 0.024982761591672897, -0.13620056211948395, 0.09345708787441254, 0.11604277789592743, -0.15898670256137848, -0.009955395013093948, 0.041234515607357025, -0.11718805134296417, 0.009156934916973114, -0.1995963156223297, 0.10123957693576813, -0.15783585608005524, -0.005183347966521978, 0.0727672129869461, 0.1129453033208847, 0.10923732072114944, -0.05938120558857918, 0.049801431596279144, 0.016851963475346565, 0.07856263220310211, -0.06848549842834473, -0.09705165028572083, -0.05795188620686531, -0.036318134516477585, -0.10888756811618805, -0.03653722256422043, 0.04990389570593834, 0.07845704257488251, -0.08661183714866638, 0.11370664089918137, 0.09898631274700165, 0.0825294554233551, 0.05902943015098572, -0.020591173321008682, -0.1104830801486969, 0.14974787831306458, -0.0025380239821970463, 0.0026145908050239086, 0.0745193362236023, -0.09304767847061157, -0.030823353677988052, -0.13323169946670532, -0.09945683926343918, -0.1695764809846878, -0.1372741460800171, -0.07921850681304932, 0.022387566044926643, -0.13863325119018555, -0.04479220137000084, -0.01415456272661686, 0.03175527974963188, -0.06297113001346588, -0.13687090575695038, 0.014294955879449844, 0.038552217185497284, -0.021056560799479485, 0.11875419318675995, 0.07628633081912994, 0.09903576970100403, 0.16181398928165436, 0.08722013235092163, 0.1352476179599762, -0.24838918447494507, 0.05995547026395798, 0.0743987038731575, 0.16039317846298218, -0.05843697488307953, 0.055579133331775665, -0.058172665536403656, 0.057675741612911224, 0.0024831723421812057, 0.005144196562469006, 0.04759656637907028, -0.16756680607795715, 0.01817612536251545, 0.12253828346729279, -0.10990513861179352, 0.05222327262163162, 0.1681312620639801, -0.01535821333527565, 0.019541841000318527, 0.06826134026050568, 0.10782395303249359, 0.0709410309791565, -0.036598045378923416, 0.013320058584213257, -0.008289762772619724, -0.001246594823896885, 0.001611191313713789, -0.09419108182191849, 0.06384823471307755, 0.0554252490401268, -0.0734320878982544, 0.045933566987514496, 0.017535824328660965, -0.05156061798334122, -0.024750055745244026, -0.21123360097408295, 0.2169739007949829, -0.20090466737747192, 0.08947086334228516, 0.2775340676307678, -0.12256613373756409, -0.10029015690088272, -0.04265568405389786, 0.030848708003759384, 0.036515604704618454, 0.1486423909664154, -0.03808491677045822, 0.010526067577302456, 5.317732200976573e-33, -0.18330447375774384, 0.0005933362990617752, 0.016836920753121376, -0.047620031982660294, 0.02358764037489891, 0.056573424488306046, -0.022337643429636955, -0.06440289318561554, -0.09912965446710587, 0.0010678088292479515, -0.13821205496788025, 0.28957560658454895, 0.06856182962656021, 0.04950333014130592, 0.032621316611766815, -0.10192511975765228, -0.23883533477783203, -0.0162168238312006, -0.08114282786846161, 0.03606930002570152, 0.10828274488449097, -0.008758876472711563, 0.05363558605313301, 0.023860018700361252, 0.17767593264579773, 0.017330611124634743, -0.045333512127399445, 0.04663340374827385, 0.09300161153078079, 0.06341391056776047, -0.16826973855495453, -0.09026727825403214, 0.11076526343822479, -0.11977875232696533, 0.03017527051270008, -0.017044294625520706, -0.04650264233350754, -0.1459130197763443, -0.016853366047143936, -0.025151832029223442, -0.11167874932289124, -0.03570183739066124, -0.0730193704366684, -0.1270674467086792, -0.17186041176319122, 0.02901480905711651, 0.10992170870304108, 0.01856149174273014, 0.06517188251018524, 0.06041792780160904, 0.08342015743255615, -0.01938255876302719, -0.037510547786951065, -0.12280509620904922, -0.1333584189414978, 0.10712642222642899, 0.12278278917074203, -0.016348622739315033, -0.036611784249544144, -0.07285645604133606, -0.0371878519654274, 0.029482832178473473, 0.0031054969877004623, 0.025766458362340927, -0.03308887779712677, 0.15710921585559845, 0.09771071374416351, 0.08254826068878174, -0.010433042421936989, 0.09876284748315811, -0.11962130665779114, 0.05181492865085602, -0.018718723207712173, -0.031032077968120575, 0.0660727471113205, 0.019324418157339096, 0.10534334182739258, 0.03420255333185196, 0.05486881360411644, 0.042997755110263824, -0.12407524883747101, -0.02836940437555313, 0.009954273700714111, 0.08076486736536026, 0.09170841425657272, 0.04316750913858414, 0.05825667828321457, 0.061702288687229156, 0.016066662967205048, -0.026077646762132645, -0.01967397704720497, -0.0419096015393734, -0.004999351687729359, 0.2335847020149231, -0.0029641520231962204, -7.071931236916304e-33, -0.0022346749901771545, -0.026682961732149124, 0.15783977508544922, 0.02858593501150608, -0.03363708779215813, 0.07296185195446014, 0.1289198100566864, -0.12560859322547913, 0.046296969056129456, -0.0365682952105999, -0.0018833749927580357, -0.026032449677586555, -0.09387961030006409, 0.005793427117168903, -0.06257057189941406, -0.0893116444349289, -0.053117237985134125, 0.04831729456782341, -0.1253722608089447, -0.08758596330881119, 0.07878576219081879, 0.1038578599691391, -0.06970007717609406, 0.0907534509897232, -0.011120995506644249, -0.0732552707195282, 0.09224334359169006, 0.05912569537758827, 0.046384185552597046, -0.02893301285803318, -0.009268618188798428, -0.11434580385684967, -0.245561420917511, -0.10067464411258698, 0.029063772410154343, 0.01539572887122631, 0.05296458303928375, -0.014491425827145576, -0.04446650296449661, 0.020833373069763184, 0.1563294231891632, -0.11963251233100891, 0.0270573478192091, 0.08514417707920074, -0.0991060733795166, 0.05635078251361847, -0.10852902382612228, -0.12320151180028915, -0.13741467893123627, 0.1330270767211914, -0.14616084098815918, -0.13394898176193237, -0.03143329918384552, 0.058848731219768524, -0.10917765647172928, 0.056354548782110214, 0.07274720072746277, 0.08863812685012817, -0.08422889560461044, 0.07803350687026978, 0.16339918971061707, 0.09424231946468353, -0.02110629715025425, 0.14680084586143494, 0.1845715343952179, -0.11408782005310059, -0.045130230486392975, -0.05417356267571449, -0.16044805943965912, 0.19914084672927856, -0.02679687738418579, -0.012257987633347511, -0.18681979179382324, -0.07128730416297913, -0.10012105107307434, 0.12925991415977478, -0.019957203418016434, -0.008949062786996365, -0.08566635847091675, -0.006962702609598637, 0.04569822549819946, -0.0007051965221762657, 0.03677910193800926, 0.009456159546971321, 0.053550977259874344, 0.14085152745246887, 0.08081556856632233, 0.06895953416824341, 0.15265998244285583, 0.01874171756207943, 0.014931971207261086, 0.015928618609905243, 0.011170703917741776, 0.09250420331954956, -0.17732106149196625, -1.0039578768328283e-07, -0.08173853904008865, 0.12762531638145447, -0.17922687530517578, -0.018137678503990173, 0.0006882231682538986, -0.03197529911994934, -0.06541293859481812, -0.1280750185251236, -0.10509146004915237, 0.004013935104012489, 0.271190881729126, -0.05581461638212204, -0.16606348752975464, -0.12018655240535736, 0.003969317302107811, -0.012768533080816269, -0.12657050788402557, -0.004205044358968735, -0.07560096681118011, -0.01543502788990736, -0.1013273298740387, 0.024050481617450714, -0.0714813619852066, 0.17210301756858826, 0.023257862776517868, -0.07141397148370743, 0.050359465181827545, 0.2212732434272766, 0.1412469446659088, -0.01415235921740532, -0.03286462649703026, -0.034248631447553635, -0.07501506805419922, 0.038339290767908096, -0.014077108353376389, -0.12191377580165863, -0.07482458651065826, 0.1147548034787178, 0.13370248675346375, 0.08120344579219818, 0.05598064512014389, 0.00972767174243927, -0.03714646026492119, -0.023994047194719315, 0.04913410171866417, 0.07821305096149445, -0.14870694279670715, -0.06560106575489044, 0.05393063277006149, -0.1305168718099594, 0.02499377727508545, -0.08269140869379044, -0.09716254472732544, 0.12229926884174347, -0.06650377064943314, 0.041033219546079636, -0.07423964887857437, 0.014841405674815178, 0.08527928590774536, -0.015776878222823143, -0.05689192935824394, -0.16285094618797302, 0.08711729198694229, 0.10012999176979065], "changes": {"1wk": -7.346941357302347, "1mo": -10.204081434053666}}, {"text": "Nitches Inc. Updates Shareholders on Amazon Integration, GovX Integration, and 2025 Growth Strategy for InTheZone Labs Nitches, inc Wed, Dec 18, 2024, 5:00 PM 5 min read In This Article: NICH -11.19% LAS VEGAS, NV / ACCESSWIRE / December 18, 2024 / Nitches Inc. (OTC PINK:NICH) is pleased to share key updates regarding the recent strides made with its InTheZone Labs brand, highlighting successful integration on Amazon, a new partnership with GovX, and continued expansion into 2025 as consumer demand for nutraceuticals and nootropics continues to accelerate. Amazon Integration and Expansion InTheZone Labs has successfully launched two flagship products- InTheZone Focused Extreme and InTheZone Focused Youth -on Amazon, the world's largest e-commerce platform. 1. InTheZone Focused Extreme : Designed for adults seeking peak mental performance, this premium nootropic and nutraceutical supplement enhances mental clarity, focus, and cognitive support. Ideal for high-achievers, professionals, and anyone looking to unlock their full potential. Shop Now : InTheZone Focused Extreme on Amazon 2. InTheZone Focused Youth : A game-changing solution for today's overstimulated youth, this bioceutical-grade supplement provides a natural alternative to overstimulation, promoting focus, cognitive function, and mental clarity. In a time of increasing distractions and reliance on pharmaceutical options, parents now have a safe and natural way to support their children. Shop Now : InTheZone Focused Youth on Amazon As families navigate the busy end-of-year season, InTheZone Focused Youth offers a timely solution for improved focus and attention. GovX Integration - Supporting Veterans and First Responders InTheZone Labs is proud to announce its partnership with GovX , a leading platform providing exclusive discounts to military, police, fire, EMS, and other first responders. This initiative aligns perfectly with the brand's mission to deliver focus-enhancing solutions to those who give so much to their communities. 30% Discount : Verified GovX members can now access InTheZone Labs products at an exclusive 30% discount through the GovX verification process. This partnership underscores our commitment to supporting the mental clarity, resilience, and well-being of veterans, first responders, and their families during this critical time of year. What is GovX? GovX serves over 8 million verified heroes across the United States, offering trusted products at discounted rates to those who serve. InTheZone Labs' alignment with GovX ensures that military, police, firefighters, medical professionals, and their families can access premium nootropic and nutraceutical supplements to optimize performance, recovery, and mental clarity. YouTube Expansion - Education and Testimonials InTheZone Labs continues to build its presence on YouTube to educate consumers on the science, benefits, and success stories behind its products. Story Continues Explore product videos, customer testimonials, and in-depth ingredient breakdowns to discover how InTheZone products can help you #GetInTheZone . Subscribe Now : InTheZone Labs YouTube Channel Check out former WWE Champion and Olympic Gold Medalist Kurt Angle 's inspirational message as he shares how InTheZone Labs helps others stay sharp and GetInTheZone for 2025: Watch Here . Strategic Growth for 2025 As we approach the new year, InTheZone Labs is laying the groundwork for exponential growth. Website Redesign : A fully revamped corporate website is in progress, offering an improved customer experience and expanded access to products. Influencer Collaborations : We are actively working with notable public figures and influencers to expand our reach and visibility. Nutraceuticals & Nootropics Market - A Billion-Dollar Opportunity The global nutraceuticals market is projected to reach $620 billion by 2030 , driven by increased consumer demand for natural health solutions. Similarly, the nootropics market is expected to grow at a CAGR of 14.6% , fueled by the rising need for cognitive enhancers and mental clarity solutions. InTheZone Labs is uniquely positioned to capitalize on this growth, with products delivering tangible results: Improved focus and clarity Elimination of brain fog Enhanced cognitive performance and vitality From corporate professionals to students, parents, and first responders, InTheZone products are designed to help individuals unlock their edge and redefine their potential for 2025. Positive Feedback Driving Success Customer testimonials have highlighted the profound impact of InTheZone Labs products: Enhanced mental clarity and sharper focus Reduced stress and improved sleep quality Increased energy without overstimulation Let's be clear: in a world where too many rely on synthetic drugs like Adderall or Ritalin, InTheZone's formulations offer a clean, natural edge-no harsh chemicals, no unnecessary risks. Every ingredient is sourced and crafted in America, with the kind of exacting standards that reflect our belief in pure performance and honest transparency. It's a move away from crutches and side effects, straight toward focus you can trust. With a few clicks on Amazon, you're not just buying a supplement; you're taking a step toward sharper clarity and a healthier tomorrow. As these results continue to resonate with consumers, InTheZone Labs stands ready to become a dominant player in the nutraceuticals space, ensuring consistent growth and shareholder value in the coming year. Looking Ahead We are only getting started. With growing sales channels like Amazon, meaningful partnerships like GovX, and a commitment to continuous innovation, Nitches Inc. and InTheZone Labs are poised to achieve significant milestones in 2025. We invite shareholders, partners, and customers to follow our journey as we continue to redefine human performance with science-backed solutions. For more information about InTheZone Labs, visit : https://inthezonelabs.com/ FDA Disclaimer : These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition. Forward-Looking Statements: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as \"anticipates,\" \"expects,\" \"intends,\" \"plans,\" \"believes,\" \"seeks,\" \"estimates,\" and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Contact Information John Morgan Ceo info@nitchescorp.com SOURCE: Nitches, inc View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2024-12-18T14:00:00+00:00", "sentiment": {"score": 0.7553369011729956, "confidence": 0.7632956504821777, "probabilities": {"positive": 0.7632956504821777, "negative": 0.007958749309182167, "neutral": 0.22874554991722107}}, "embedding": [-0.05528152734041214, -0.029737289994955063, -0.016309432685375214, -0.06599809974431992, 0.1504727005958557, -0.02534179575741291, 0.069078728556633, 0.1861274540424347, -0.016132891178131104, 0.12479528784751892, -0.01999387890100479, 0.024535370990633965, 0.05865740031003952, -0.03228075057268143, 0.07593238353729248, 0.0031262359116226435, 0.15894350409507751, -0.07477235049009323, -0.18489721417427063, -0.059620071202516556, 0.037711262702941895, -0.009087152779102325, 0.024571923539042473, -0.05038059130311012, -0.2381061613559723, 0.177562415599823, -0.1958341896533966, -0.03165893256664276, -0.1014753133058548, -0.11133339256048203, 0.19040608406066895, 0.17520135641098022, 0.07325255870819092, -0.05015543848276138, -0.07065434753894806, -0.07735191285610199, 0.0006477925926446915, 0.03374982252717018, -0.1369912475347519, -0.14251312613487244, -0.0016336399130523205, -0.07708186656236649, -0.10694364458322525, 0.0034477105364203453, -0.022986814379692078, -0.2147018015384674, -0.04692073166370392, -0.010235362686216831, 0.06386494636535645, 0.09828919172286987, -0.12563784420490265, -0.20786640048027039, 0.11877270042896271, 0.01763405092060566, 0.0015382110141217709, 0.06864506006240845, -0.16901418566703796, 0.019013764336705208, -0.08280599862337112, -0.029383454471826553, 0.053722236305475235, -0.13255909085273743, 0.00229150103405118, 0.02026873268187046, 0.054666243493556976, 0.11773647367954254, 0.11065879464149475, -0.03661058098077774, -0.020113756880164146, -0.17736601829528809, -0.05346561223268509, -0.12252088636159897, 0.022330785170197487, 0.10636639595031738, 0.07901078462600708, 0.2150880992412567, 0.18101346492767334, -0.0116848424077034, 0.17534592747688293, -0.089808888733387, 0.007983095943927765, 0.16076186299324036, 0.06671091914176941, 0.013431776314973831, -0.031957320868968964, 0.03008030354976654, 0.018936220556497574, 0.08544336259365082, 0.05509854853153229, -0.008062582463026047, 0.022994624450802803, -0.07607872039079666, 0.09392522275447845, 0.02145829237997532, 0.05173659324645996, -0.0959828644990921, -0.13874860107898712, -0.07640638202428818, -0.093492791056633, 0.03326161950826645, 0.09071984887123108, 0.053092360496520996, -0.0266721211373806, -0.1084509938955307, -0.13194823265075684, -0.09672395139932632, 0.019016794860363007, 0.08198851346969604, 0.0822020098567009, 0.08751503378152847, -0.19154536724090576, 0.0010318402200937271, 0.06434798240661621, 0.028595026582479477, -0.0633750930428505, 0.11285056173801422, 0.016841642558574677, 0.00974699854850769, 0.2417784035205841, -0.0621483288705349, 0.07904823124408722, 0.08900125324726105, 0.025015084072947502, -0.005118158645927906, 0.016496596857905388, 0.04617540165781975, 0.017006713896989822, 1.1380702841119522e-32, -0.1774921715259552, 0.12810343503952026, -0.045962072908878326, 0.011273841373622417, -0.05121796205639839, 0.029536381363868713, 0.06633205711841583, 0.010182734578847885, -0.16444483399391174, -0.021672233939170837, -0.11080485582351685, 0.21132603287696838, -0.027989264577627182, 0.2228901982307434, 0.03076060488820076, -0.08059768378734589, -0.15011240541934967, 0.06803212314844131, 0.05744542181491852, 0.10751666128635406, -0.031409379094839096, 0.08781245350837708, -0.011571457609534264, 0.004716038703918457, 0.10771197825670242, 0.1408492624759674, -0.005457833409309387, 0.09659314155578613, 0.1312602311372757, 0.03118443489074707, -0.1445184350013733, -0.0389636792242527, -0.03887070342898369, -0.10238752514123917, -0.12602363526821136, -0.08368715643882751, 0.06719240546226501, -0.09300609678030014, -0.10101866722106934, -0.05581203103065491, -0.11675916612148285, 0.09408338367938995, -0.0854560062289238, 0.06610968708992004, 0.05227530747652054, 0.015720952302217484, -0.014641000889241695, -0.014532119035720825, 0.0612153559923172, 0.008303984999656677, -0.07525172084569931, 0.05152803659439087, 0.043611228466033936, -0.18598923087120056, -0.12313081324100494, 0.04806029796600342, -0.021149221807718277, -0.05660266429185867, 0.099318727850914, -0.12843774259090424, 0.06606480479240417, -0.10888811945915222, -0.11563420295715332, 0.0047364551573991776, -0.007952442392706871, -0.014738581143319607, 0.07617184519767761, 0.02589300274848938, -0.012567460536956787, 0.0998845100402832, -0.06174536049365997, 0.08541014790534973, 0.19118860363960266, 0.0007514525204896927, 0.05963123217225075, -0.0747690498828888, -0.052648961544036865, 0.07305920124053955, 0.02557412162423134, -0.06732118874788284, 0.10964550077915192, 0.01995944418013096, -0.060555599629879, 0.059258412569761276, 0.00872139073908329, -0.03196793049573898, -0.011348364874720573, 0.12149465829133987, -0.11109811067581177, -0.19430358707904816, 0.05331426113843918, -0.04599124938249588, 0.010884946212172508, 0.14894524216651917, -0.07844728231430054, -9.367699622063064e-33, 0.0046450188383460045, -0.1261100172996521, -0.14165620505809784, 0.08819824457168579, 0.1155494675040245, 0.08867432177066803, 0.133744478225708, -0.1558384895324707, 0.04213089868426323, -0.09155616909265518, 0.00467655248939991, 0.027447141706943512, -0.00022232718765735626, -0.06188782677054405, -0.02655579149723053, -0.04702182114124298, -0.01912240870296955, -0.017115790396928787, -0.07087787985801697, -0.0849168598651886, 0.043937962502241135, 0.12410124391317368, -0.15703648328781128, 0.027516208589076996, -0.01103231217712164, 0.09991323947906494, 0.04996764287352562, 0.07180514186620712, 0.018376946449279785, 0.06270139664411545, -0.022956252098083496, 0.06920953840017319, -0.1317926049232483, -0.030345143750309944, -0.02874060533940792, 0.027590755373239517, -0.05910849943757057, -0.11682787537574768, -0.20614835619926453, -0.0845348909497261, -0.06232444569468498, 0.09345856308937073, -0.03646506741642952, 0.04538791626691818, -0.06422238051891327, 0.1368604600429535, -0.050743747502565384, -0.08621236681938171, -0.12117158621549606, 0.13906551897525787, 0.0038075107149779797, 0.06911394000053406, 0.002727065235376358, -0.011763468384742737, -0.0280854981392622, 0.02341822162270546, 0.00016869604587554932, -0.03612067177891731, -0.06332819163799286, -0.0032741851173341274, 0.00563002610579133, 0.05763842537999153, -0.04454530030488968, -0.009236406534910202, 0.027677016332745552, 0.004395551048219204, 0.02316250093281269, 0.04714704677462578, -0.033024463802576065, 0.07437071949243546, 0.042702872306108475, 0.008916265331208706, 0.00578481238335371, -0.23266366124153137, -0.010351104661822319, 0.07735566794872284, 0.05804189294576645, -0.04789312928915024, -0.17636021971702576, -0.0603439137339592, -0.05070934817194939, -0.11470034718513489, 0.045832641422748566, 0.018940450623631477, 0.011827321723103523, 0.1334942728281021, -0.04481499642133713, 0.09922093152999878, 0.010192634537816048, 0.06898435950279236, -0.15399819612503052, -0.019305702298879623, -0.2505561113357544, 0.13125675916671753, -0.03794785961508751, -1.0074293754769315e-07, 0.13465675711631775, -0.08327821642160416, -0.1614382565021515, 0.07856440544128418, 0.05019063502550125, -0.025034574791789055, -0.07263670861721039, 0.12984317541122437, 0.021988142281770706, 0.208970844745636, 0.1698628067970276, -0.01015704870223999, -0.07745756208896637, 0.09038016200065613, 0.08113259077072144, 0.03502728417515755, 0.14718978106975555, 0.05886420980095863, -0.05139914155006409, -0.024630997329950333, -0.10402180254459381, 0.10193662345409393, -0.04773180931806564, -0.15646499395370483, 0.05969027429819107, -0.05012495070695877, -0.08537264168262482, 0.05007551610469818, 0.006397385150194168, 0.04744920879602432, -0.029756970703601837, 0.037203941494226456, -0.001596878981217742, 0.009885967709124088, -0.07984611392021179, -0.08926890790462494, 0.15341897308826447, 0.11619437485933304, 0.023468106985092163, 0.040703222155570984, -0.003105154959484935, 0.03964081406593323, -0.03282960131764412, -0.00688495859503746, -0.02221098355948925, -0.09497670829296112, -0.12527048587799072, -0.1007663831114769, 0.11865290999412537, -0.046076830476522446, -0.09578436613082886, 0.009957517497241497, -0.01842508092522621, 0.007894403301179409, 0.0011602716986089945, 0.03770305588841438, -0.07162889093160629, -0.047788918018341064, 0.03216702118515968, 0.09476447105407715, 0.17542526125907898, -0.1027664840221405, 0.07183586061000824, 0.06143255531787872], "changes": {"1wk": 0.8928562875609045, "1mo": 0.0}}, {"text": "Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges GuruFocus News Wed, Nov 13, 2024, 10:16 AM 3 min read In This Article: GOVXW -22.92% Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript . Positive Points Geovax Labs Inc ( NASDAQ:GOVX ) received a significant BARDA Project NextGen Award valued at almost $400 million, supporting a 10,000 patient comparative trial. The company is advancing its vaccine candidate against monkeypox and smallpox, with production of the first CGMP clinical substance batch underway. Geovax Labs Inc ( NASDAQ:GOVX ) is progressing with its advanced MVA manufacturing process, which could enhance production efficiency. The company is actively pursuing business partnerships and collaborations for worldwide development and commercialization. Geovax Labs Inc ( NASDAQ:GOVX ) reported increased revenues of $2.8 million for the third quarter, reflecting progress in its BARDA contract. Negative Points Geovax Labs Inc ( NASDAQ:GOVX ) reported a net loss of $16.7 million for the first nine months of 2024, primarily driven by manufacturing activities and costs associated with the BARDA contract. The company faces challenges in the competitive landscape, with potential development of more effective or easier-to-use products by competitors. There is uncertainty regarding the timing of regulatory approvals and the ability to meet expedited pathways for its vaccine candidates. Geovax Labs Inc ( NASDAQ:GOVX ) has ongoing financial needs to support its clinical programs and development activities, requiring careful capital management. The company is dependent on successful partnerships and collaborations to achieve its commercialization and distribution goals. Q & A Highlights Warning! GuruFocus has detected 3 Warning Signs with GOVX. Q : What are the steps required to submit test batches for the A GE one cell line for MVA manufacturing to the FDA, and what is the expected timeline? A : Mark Newman, Chief Scientific Officer, explained that the process involves standard regulatory evaluations, including purifying the virus to FDA standards. The process development is just starting, and it is estimated to take a minimum of 18 months, although it could be expedited with more resources if necessary. Q : When can we expect interim and final results for the CLL and healthy volunteer trials? A : David Dunn, CEO, stated that interim results for the CLL study are expected by the end of the year, while final results for the healthy volunteer trial might extend into early next year. The company is pushing for both to be reported by year-end. Q : What progress has been made in seeking an expedited regulatory pathway for the OX vaccine, and when will the 10,000-patient Phase 2 COVID trial start enrolling? A : John Sharkey, VP of Business Development, mentioned active engagement with regulators, indicating an expedited pathway involving abbreviated trials. Kelly McKee, Chief Medical Officer, added that enrollment for the COVID trial is projected to begin in early October 2025. Story Continues Q : What are the next steps for the primary vaccine trial, CLL trial, and booster vaccine trial after data release? A : David Dunn, CEO, noted that the company will evaluate interim results from the CLL trial for potential expedited development. The healthy volunteer trial results will inform the larger Project Nextgen trial. The stem cell transplant trial continues to enroll, with additional sites being added. Q : How does the collaboration and partnership environment look currently, and what is the expected revenue from the Barda contract? A : John Sharkey, VP of Business Development, noted increased engagement and interest in partnerships, particularly for the GEP and CM04 S1 vaccines. Mark Reynolds, CFO, explained that revenue from the Barda contract is on a cost reimbursement basis, with approximately $3 million expected per quarter. For the complete transcript of the earnings call, please refer to the full earnings call transcript . This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "GOVX", "date": "2024-11-13T07:16:47+00:00", "sentiment": {"score": 0.6071861274540424, "confidence": 0.6322069764137268, "probabilities": {"positive": 0.6322069764137268, "negative": 0.025020848959684372, "neutral": 0.34277209639549255}}, "embedding": [-0.08292941749095917, -0.08375072479248047, 0.06734176725149155, -0.08678081631660461, -0.08012228459119797, -0.03670022636651993, -0.03778449445962906, 0.09787020832300186, 0.027145881205797195, 0.0876590758562088, -0.05571369826793671, -0.006057887338101864, 0.18831080198287964, 0.1003275066614151, -0.09782454371452332, -0.06725898385047913, 0.03957275673747063, -0.0858910083770752, -0.049523334950208664, 0.11510494351387024, 0.09741413593292236, -0.03511127084493637, -0.00023830868303775787, -0.06468549370765686, -0.024702327325940132, 0.017652928829193115, -0.06700258702039719, -0.0987609326839447, -0.0654023140668869, -0.02725549228489399, -0.007635351270437241, 0.11823929846286774, 0.008854548446834087, -0.0985269695520401, 0.04179879650473595, 0.06804510951042175, -0.021027185022830963, 0.04632601886987686, -0.013058926910161972, 0.03282560035586357, -0.004216896835714579, -0.08771061897277832, -0.18828728795051575, 0.06345734000205994, 0.06973849982023239, -0.1881822943687439, -0.006462177261710167, -0.07866892218589783, 0.013893643394112587, 0.08061692118644714, -0.1617567539215088, -0.23381929099559784, 0.0587933249771595, 0.028409603983163834, -0.09489737451076508, -0.039461709558963776, -0.07264192402362823, -0.10717062652111053, -0.0004885807866230607, -0.028178203850984573, -0.03748117759823799, -0.06901317089796066, -0.05901888757944107, 0.019059769809246063, 0.24076969921588898, 0.03746191784739494, 0.09147004783153534, -0.09391918778419495, -0.06338346749544144, -0.1421111524105072, 0.034032657742500305, -0.004259729757905006, -0.07507093250751495, 0.01902218721807003, -0.07745908200740814, 0.24823808670043945, 0.20240221917629242, 0.11877132952213287, 0.24260249733924866, -0.10780137777328491, 0.09023160487413406, 0.07314962893724442, -0.0027603753842413425, 0.07709567248821259, -0.05174636095762253, 0.08599548041820526, 0.09284783899784088, 0.17601220309734344, 0.1167956292629242, 0.002223254181444645, 0.08933792263269424, 0.022840561345219612, 0.007891349494457245, 0.02838924527168274, 0.06757907569408417, -0.00723645556718111, -0.03468228876590729, -0.006699597463011742, 0.16822046041488647, -0.024611499160528183, 0.10836748778820038, -0.1084805428981781, 0.003923623822629452, -0.12119390070438385, -0.1004219651222229, -0.06565497070550919, -0.05545193701982498, 0.0021456535905599594, -0.008473331108689308, 0.037488095462322235, -0.14117752015590668, 0.11375673115253448, 0.012460706755518913, -0.06250077486038208, -0.08540868759155273, 0.3387868404388428, -0.03355203941464424, 0.001743227243423462, 0.11924296617507935, -0.14449994266033173, 0.06042839214205742, -0.06605197489261627, -0.005812805145978928, -0.11751177906990051, 0.04366013780236244, 0.05792061239480972, -0.058646589517593384, 1.0261471323347435e-32, -0.06500652432441711, -0.01567722298204899, 0.045850563794374466, -0.05822733789682388, -0.021397318691015244, 0.12259738147258759, 0.04474829137325287, 0.02861093357205391, -0.17682087421417236, -0.05757517367601395, -0.2216421365737915, 0.2025030553340912, -0.04982885718345642, 0.10655611753463745, -0.023421451449394226, -0.05799400806427002, 0.039422910660505295, 0.015814131125807762, -0.07205317914485931, 0.01720162108540535, 0.06478212028741837, -0.09267643094062805, 0.07388713955879211, 0.04857950657606125, 0.10072395205497742, 0.037934448570013046, -0.12419082224369049, 0.0016275616362690926, -0.07918442785739899, 0.013928378000855446, -0.029128223657608032, 0.020159918814897537, 0.03061641938984394, -0.023378631100058556, -0.05320390686392784, -0.06444219499826431, -0.07333409041166306, -0.1256246268749237, 0.05351007357239723, 0.0037558029871433973, -0.08134748041629791, 0.1637435108423233, 0.0834370106458664, -0.07412698864936829, -0.007343974895775318, -0.07724159955978394, -0.06918797641992569, -0.09286083281040192, 0.034901127219200134, 0.047637686133384705, -0.01083979569375515, 0.21187451481819153, -0.08463598787784576, -0.1015491932630539, -0.03324250131845474, 0.07508012652397156, 0.058025289326906204, -0.06207764893770218, 0.027881525456905365, 0.1876024752855301, 0.025745077058672905, 0.10067614912986755, -0.1019427478313446, 0.13134559988975525, -0.08992110937833786, 0.06940387189388275, 0.041739314794540405, 0.037962980568408966, 0.012708302587270737, 0.14786192774772644, -0.03293180465698242, 0.03580433875322342, 0.036968499422073364, -0.1421208381652832, 0.1294189989566803, -0.19474944472312927, 0.048237234354019165, -0.0023238034918904305, 0.03971264511346817, -0.03551035374403, -0.013418341055512428, 0.03891027718782425, -0.01152225024998188, 0.06188763678073883, 0.008970480412244797, -0.03692173585295677, 0.025400564074516296, 0.147957444190979, -0.11620178073644638, -0.04841527342796326, -0.013771390542387962, -0.026584694162011147, -0.09290000796318054, 0.14411982893943787, 0.034051328897476196, -1.071912286553323e-32, -0.0648980587720871, -0.02574528008699417, -0.002209617756307125, -0.061487555503845215, 0.019021546468138695, -0.0016624536365270615, 0.11605104804039001, -0.09049075841903687, 0.0643964633345604, -0.06298264116048813, -0.02981436252593994, 0.09975548088550568, 0.06299614161252975, 0.16887661814689636, -0.14163312315940857, 0.052557721734046936, 0.002238307148218155, -0.15367087721824646, -0.11143659055233002, -0.10931556671857834, 0.08637601882219315, 0.25211238861083984, -0.0729033499956131, 0.07137404382228851, -0.02296493761241436, 0.005793538875877857, 0.044677119702100754, 0.10267036408185959, 0.03956303000450134, -0.0017305177170783281, -0.14322175085544586, 0.07855379581451416, -0.22833916544914246, 0.019767750054597855, 0.035768069326877594, -0.14520469307899475, 0.19135922193527222, -0.17675036191940308, 0.09707185626029968, -0.051697999238967896, 0.11101764440536499, 0.02921408601105213, -0.07716910541057587, -0.051322098821401596, 0.02969100885093212, 0.09949412941932678, 0.07221288979053497, -0.08223935216665268, 0.0769866481423378, 0.13032089173793793, -0.02320859581232071, 0.030099766328930855, -0.011582281440496445, 0.047138288617134094, -0.10236014425754547, -0.08714869618415833, 0.017499689012765884, -0.07524488866329193, -0.02351159043610096, 0.013600993901491165, 0.012126545421779156, 0.14756281673908234, 0.04098036140203476, -0.019585072994232178, 0.04468628391623497, 0.1493658721446991, 0.15811309218406677, -0.006827149074524641, 0.0526556521654129, -0.1328882873058319, -0.021076545119285583, 0.06044541671872139, -0.10265649110078812, -0.19084089994430542, 0.02082371897995472, 0.09248010814189911, -0.16489064693450928, -0.08176904171705246, -0.046337563544511795, -0.06695006787776947, 0.17945870757102966, -0.033640049397945404, 0.09538371115922928, 0.013471100479364395, 0.11367839574813843, 0.2227691113948822, 0.025825800374150276, -0.03382518142461777, -0.0026047425344586372, 0.09477809816598892, -0.16068610548973083, -0.14244653284549713, -0.09462606906890869, 0.14595326781272888, 0.029769692569971085, -1.0073081568862108e-07, 0.015142376534640789, 0.018135828897356987, -0.0376146100461483, -0.044201672077178955, 0.05136876553297043, -0.03196249529719353, -0.05241786688566208, 0.04464869573712349, 0.13395361602306366, 0.13092489540576935, 0.17898903787136078, 0.054936252534389496, -0.15092729032039642, 0.10428287088871002, -0.10313297063112259, 0.041687093675136566, -0.16541437804698944, 0.04080981761217117, -0.05813505873084068, -0.13866834342479706, -0.1128884106874466, 0.04787571728229523, 0.00518442690372467, 0.045991960912942886, 0.0551111064851284, -0.15772998332977295, 0.036923497915267944, 0.1649152934551239, 0.0319114588201046, -0.09845751523971558, -0.051383811980485916, -0.046306341886520386, -0.006669505499303341, -0.0134516516700387, -0.1091141402721405, -0.1420670747756958, 0.06213856488466263, 0.11983465403318405, 0.1591370701789856, 0.10629012435674667, -0.028534170240163803, 0.05006086081266403, -0.008951826021075249, -0.08896543830633163, -0.04298035055398941, -0.052229661494493484, -0.2607601583003998, -0.143851637840271, 0.12942032516002655, -0.14369352161884308, 0.04764792323112488, -0.11126365512609482, -0.01950647309422493, 0.022571571171283722, -0.035794448107481, 0.023072771728038788, -0.1454336941242218, -0.05131365358829498, 0.02062329463660717, -0.01755407825112343, 9.27504152059555e-05, -0.3177712559700012, 0.11758600175380707, -0.0337333083152771], "changes": {"1wk": 7.7777790532680955, "1mo": -11.111109148818315}}]